WO2010140117A1 - Method and system for providing behavioural therapy for insomnia - Google Patents

Method and system for providing behavioural therapy for insomnia Download PDF

Info

Publication number
WO2010140117A1
WO2010140117A1 PCT/IB2010/052440 IB2010052440W WO2010140117A1 WO 2010140117 A1 WO2010140117 A1 WO 2010140117A1 IB 2010052440 W IB2010052440 W IB 2010052440W WO 2010140117 A1 WO2010140117 A1 WO 2010140117A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
sleep
score
insomnia
structured
Prior art date
Application number
PCT/IB2010/052440
Other languages
French (fr)
Inventor
Elke Naujokat
Sandrine Devot
William Hoos
Hui Zhang
Antonius Johannes Josephus Rademakers
Original Assignee
Koninklijke Philips Electronics, N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips Electronics, N.V. filed Critical Koninklijke Philips Electronics, N.V.
Priority to JP2012513716A priority Critical patent/JP5775868B2/en
Priority to RU2011154352/14A priority patent/RU2568354C2/en
Priority to AU2010255354A priority patent/AU2010255354A1/en
Priority to US13/375,325 priority patent/US8979730B2/en
Priority to CN201080024189.8A priority patent/CN102448368B/en
Priority to EP10727937A priority patent/EP2437652A1/en
Priority to BRPI1009049A priority patent/BRPI1009049A2/en
Publication of WO2010140117A1 publication Critical patent/WO2010140117A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1118Determining activity level
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/113Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb occurring during breathing
    • A61B5/1135Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb occurring during breathing by monitoring thoracic expansion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4806Sleep evaluation
    • A61B5/4809Sleep detection, i.e. determining whether a subject is asleep or not
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4806Sleep evaluation
    • A61B5/4812Detecting sleep stages or cycles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6802Sensor mounted on worn items
    • A61B5/6804Garments; Clothes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09BEDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B19/00Teaching not covered by other main groups of this subclass
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4806Sleep evaluation
    • A61B5/4815Sleep quality
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7264Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A61B5/7267Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems involving training the classification device
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Definitions

  • Patent Application Serial No. 61/184,165 filed June 4, 2009 entitled “System and Method for Managing Insomnia.”
  • the invention relates to a system and associated method structured to facilitate cognitive behavioral therapy for a patient having insomnia.
  • Sleep disorders are common. At least 10% of the population suffers from a sleep disorder that is clinically significant and of public health importance. Insomnia is by far the most common form of sleep disturbance.
  • insomnia definitions include descriptions of sleep-specific symptoms with associated daytime complaints.
  • Sleep symptoms typically include a difficulty initiating sleep, difficulty maintaining sleep, final awakening that occurs much earlier than desired or sleep that is non-restorative or of generally poor quality. Waking symptoms are associated with daytime complaints related to fatigue, sleepiness, mood disturbance, cognitive difficulties and social or occupational impairment.
  • insomnia is treated by medication.
  • the market for sleeping pills is about 4.6B US$.
  • Other forms of treatment such as sleep restriction therapy are less wide-spread although evidence suggests that they are more effective on the long run than pharmaceutical treatment alone.
  • a standard diagnostic method for assessing the nature and the severity of the sleep problem a so-called sleep log or sleep diary, i.e. a questionnaire usually on paper, is used in most cases; also an actigraph can be used as an alternative to a sleep log.
  • the main drawback of this sleep log is that its accuracy is affected by a subjective bias of the patient, e.g. for patients it is often difficult to remember sleep and wake periods during the night correctly.
  • U.S. Patent Application Publication No. 2004/0225179 discloses automated behavioral methods and systems for treating insomnia that use passive means for determining wake/sleep states and is incorporated herein by reference.
  • Insomnia is a prevalent sleep disturbance in the general population.
  • patients tend to not seek treatment or are diagnosed by a non sleep specialist, e.g. a GP, without the use of a standard and proper method for assessing the nature and the severity of the sleep problem. This usually results in the underestimation of the reality of the sleep problem and/or the prescription of sleeping pills, although a drug-free therapy - the cognitive behavioural therapy for insomnia (CBT-I) - has been shown to be as effective and more sustainable. Further, a more accurate assessment and a tailored therapy may lead to a higher compliance and consequently to a better medical outcome.
  • CBT-I cognitive behavioural therapy for insomnia
  • An object of the disclosed concept is to provide a system structured to facilitate cognitive behavioral therapy for a patient having insomnia, the system including a communication assembly structured to provide for electronic communication, a sensor system having at least one sensor, the sensor system structured to detect sleeping activity data and to provide a sensor system signal incorporating the sleeping activity data, the sensor system coupled to, and in electronic communication with, the communication assembly, a first processing unit coupled to, and in electronic communication with, the communication assembly, the first processing unit structured to receive the sensor system signal and to convert the sleeping activity data into sleep pattern data, a second processing unit having an input assembly and structured to gather patient input data, the second processing unit coupled to, and in electronic communication with, the communication assembly, a third processing unit coupled to, and in electronic communication with, the communication assembly, the third processing unit structured to receive the sleep pattern data and the patient input data, perform an analysis thereon thereby creating a patient sleep profile, a fourth processing unit coupled to, and in electronic communication with, the communication assembly, the fourth processing unit structured to analyze the patient sleep profile and to provide a course of therapy related to
  • a further object of the disclosed concept is to provide a method of providing cognitive behavioral therapy for insomnia, the method including the steps of monitoring a patient's sleep utilizing a sensor system having at least one unobtrusive sensor, the sensor system structured to detect sleeping activity data, gathering patient input data, combining the patient input data and the sleeping activity data to create a patient sleep profile, analyzing a patient's sleep profile to determine a course of therapy, and presenting the course of therapy to the patient on a display.
  • the term “patient” does not only apply on human beings, but also on animals. Further, the term “patient” does not mean that the respective person/animal is disease ridden, thus, also healthy people will be referred to as “patients.”
  • the term “sleep/wake classification” refers to the classification of the epoch of interest as “wake” or “sleep,” resulting from the probability of belonging to the respective class, or the classification "true” or “false” given as an output of the classifier but also refers to the display of the classifier results on a user interface or any device.
  • the term “pNN50” refers to the percentage of the number of interval differences of adjacent NN-Intervals greater than 50 ms
  • the term “SDNN” refers to the standard deviation of all NN-Intervals
  • the term “SDSD” refers to the Standard deviation between distances between adjacent intervals
  • the term “RR mean” refers to mean duration of the RR-Intervals
  • the term “HR mean” refers to the mean heart rate
  • LF refers to the low frequency range, as defined by heart rate variability standards
  • the term “HF” refers to the high frequency range, as defined by heart rate variability standards
  • the term “RMSSD” refers to root mean square successive differences
  • the term “HRV” refers to heart rate variability.
  • FIG. 1 schematically shows the general principle of the invention
  • FIG. 2 shows a schematic flowchart of the feature extraction method of a first preferred embodiment of the invention
  • FIG. 3 shows a schematic flowchart of the sleep/wake classification method of a first preferred embodiment of the invention
  • Fig. 4 shows the sleep restriction algorithm based on the method of the present invention
  • FIG. 5 schematically shows the elements of the invention
  • FIG. 6 shows a schematic flowchart of the method of providing cognitive behavioral therapy for insomnia
  • Fig. 7 shows a schematic flowchart related to the sleep scheduling module
  • FIG. 8 shows a schematic flowchart related to the association bed-sleep module
  • FIG. 9 shows a schematic flowchart related to the cognitive restructuring module
  • Fig. 10 shows a schematic flowchart related to the coping strategy module
  • Fig. 11 shows a schematic flowchart related to the relaxation module
  • Fig. 12 shows a schematic flowchart related to the lifestyle module.
  • the system for sleep/wake classification 100 comprises unobtrusive in- bed sensors for vital body sign monitoring 101 of the heart activity from the ECG, and/or the body movements from a bed foil sensor or the like as will be described in the following.
  • a further step is the pre-processing unit 102 for filtering and artifact removal during preparation of the signals, a feature extraction unit 103 extracting in particular features from the ECG and/or the body movements signal alone or in combination, then there is a sleep/wake classifier unit 104 for classification of the sleep /wake status according to all the input features, sleep efficiency calculation unit 105 for calculating the time asleep compared to the time in bed, used as input for the patient sleep restriction algorithm, device 106 providing, for example, rules for a healthier sleep to the patient.
  • the output of the sleep/wake classification 104, sleep efficiency calculation 105 and sleep restriction algorithm device 106 can be used to provide feedback to the patient 107 or to the medical professional, who could also get information from additional sources like the sleep log questions for subjective parameters 109.
  • the sensor is a ferro-electret foil placed underneath the patient's thorax to measure heart rate, respiration and body movements.
  • a piezo-resistive strain gauge glued onto a slat underneath the mattress in the patient's thorax region can be used to measure heart rate, respiration and body movements.
  • ECG preferably a textile ECG integrated as a pillow and foot mat electrode in the bed.
  • the ECG sensor could be combined with a respiration signal, measured with a standard (inductive or piezo- resistive) band around the thorax and/or the abdomen.
  • This type of sensor can be also integrated into textiles (e.g. a T-shirt) to make it more unobtrusive.
  • the ECG sensor could be combined with an accelerometer signal.
  • the device can be a wrist-worn device, but preferably a 2D or 3D accelerometer is placed on the patient's trunk to measure body movements. Also, this type of sensor can be integrated into textiles (e.g. a T-shirt) to make it more unobtrusive.
  • the processing unit comprises several steps as can be seen in Figure 1. These are the preprocessing of the raw data, feature extraction and the sleep/wake classification. In the following paragraphs the different alternatives for each of these steps will be described in more detail.
  • the signal pre-processing device 102 of Figure 1 includes one or more of the following steps which can be passed through serially, parallel or repeatedly: appropriate filtering of the signal(s); and artifact removal.
  • the feature extraction device 103 includes extraction of features from the ECG and a respiration signal comprising:
  • the following features are derived: statistical heart rate variability parameters from the time domain (e.g. mean heart rate, SDNN, RMSSD etc.); parameters from the heart rate variability (HRV) spectrum (e.g. LF, HF); multi-scale sample entropy; and progressive detrended fluctuation analysis.
  • HRV heart rate variability
  • the slat sensor or the inductive/piezo-resistive band - the spectrum is calculated and the LF and HF power are extracted as features.
  • the mean breathing rate is determined.
  • the feature extraction device 103 allows in case of both, the ECG signal and a respiration signal are available, to calculate the coherent power of both spectra as an additional feature.
  • the ratio of heart rate and breathing rate can be derived as an additional feature.
  • an activity index is derived based on large body movements.
  • the preferred embodiment of the present invention further suggests that for the next step - the sleep/wake classification 104 - the activity index and at least one additional feature relating to the cardiac and/or respiratory status are a preferable combination as input for the classification process.
  • a vector, of at least one feature, and preferably all or at least a sub-set of the above-mentioned features is generated for each epoch of interest, e.g. each 1 -minute segment of data.
  • this vector is fed into a sleep/wake classifier 104 which is based on a standard pattern recognition approach with supervised learning, as will be described in Figure 3.
  • the following approaches can preferably be used: Bayesian linear or quadratic discriminant classifier; support vector machine; k-Nearest-Neighbour (kNN) method; Neural Network; and Hidden Markov Model.
  • the parameters of the classifier are trained on a large database of representative data.
  • the input unit and the display unit are preferably combined in the preferred embodiment of the present invention in one user interface device 107.
  • This device can be a normal laptop PC, a tablet PC with a touch screen, a handheld device such as a PDA or a mobile phone.
  • the processing unit can also be part of this device.
  • the feedback to the patient can contain one or more of the following parameters: time in bed, total sleep time, total wake time, sleep efficiency, sleep latency, number and durations of awakenings, or a simplified hypnogram.
  • the feedback to the medical professional can be given via the same user interface 108.
  • the patient's data can be (automatically) sent to the physician via the Internet or GSM, UMTS, EDGE, GPRS, or any other Internet or mobile phone standard or system.
  • the feedback to the medical professional should contain all of the above- mentioned parameters. Furthermore, it should also contain the patient's answers to the subjective sleep log questions so that he can compare the subjective and objective data which gives him important information for the appropriate therapy approach. This is, for example, especially important in case of sleep-state misperception, a type of insomnia where objective sleep data reflect a normal sleep pattern but the patient himself does not recognize that he has slept.
  • the ECG signal provided by an ECG sensor 200 undergoes a pre-processing 201, wherein the preprocessing consists in R-peak detection, ectopic beat removal, linear interpolation and resampling at a predefined frequency, preferably at 4 Hz.
  • the resulting RR-interval series is then considered and heart rate variability parameters, according to the standard, are assessed in frequency and time domains.
  • the power spectral estimation is updated on a shorter time scale, e.g. every new detected R-peak of the ECG.
  • pNN50 percentage of the number of interval differences of adjacent NN-Intervals greater than 50 ms
  • SDNN standard deviation of all NN- Intervals
  • SDSD standard deviation of successive differences between adjacent intervals
  • RMSSD root mean square successive differences
  • RR mean mean duration of the RR-Intervals
  • HR mean mean of the instantaneous heart rate
  • Non-linear parameters are also extracted from the RR-interval time series in 206 by the application of two methods.
  • the first non-linear calculation method used in 207 is progressive detrended fluctuation analysis which allows to gradually integrate the signal before detrending over windows of length 64. Further, the partial sums of the squared signal are then considered and this provides the resulting differentiated time series in 208 from which we extract a new feature 209, defined as the maximum value over the considered epoch, preferably a one-minute epoch but which can be any predefined epoch duration.
  • the second non-linear calculation method applied to the RR-interval series provides the multiscale sample entropy.
  • the series is coarse-grained at scales 1 and 2 in 210 and 5-minute segments are considered.
  • the bed foil signal provided by bed foil sensor 213 is undergoing a pre-processing 214 which consists of noise reduction and calibration.
  • the use of low pass filtering 215 leads to the breathing signal. Peak identification on this signal allows to deduce the breath interval series, which is also linearly interpolated and resampled at a predefined rate, preferably at 4 Hz in 216.
  • the power spectrum 217 is computed using preferably an autoregressive model with advanced detrending.
  • the power spectrum is then split and normalized in 218 in the low- frequency band LF (0.04-0.15 Hz) and in the high frequency band HF (0.15-0.4 Hz), which are used to define the spectral features LF norm respi and LF/HF ratio respi.
  • the detection of small and large energy artefacts in 219 allows to define a heuristic activity index over one-minute epochs, also used as a feature in 220.
  • the band-pass filtering in 221 delivers the so-called ballistocardiogram, which represents the mechanical heart activity. This signal could be an interesting alternative to the ECG signal to get the heart rate variability signal.
  • the RR-interval and the breath interval series are combined in 222 by estimating the squared coherence function over 5- minute epochs centred on the one-minute epoch of interest.
  • This coherence function is multiplied by the autospectrum of the RR-interval series and integrated along the frequency axis.
  • the resulting feature in 223 is the amount of coherent power in %.
  • a preferred embodiment contains the features 203, 205, 209, 212, 223, 218, 220, which form the components of the feature vector used in the classification process which is further described in Figure 3.
  • Figure 3 is a preferred embodiment of the method for sleep/wake classification.
  • Step 303 represents information coming from the feature extraction process providing a vector with at least one element, which belongs to the test data set.
  • the decision is based on a supervised learning classifier 301, which is trained with a training data set 302.
  • the classifier 304 decides on the basis of a Bayesian linear or quadratic discriminant classifier, a support vector machine or the k-Nearest-Neighbour (kNN) classifier and with a supervised learning approach based on the training data set, whether the patient is awake or asleep. The more representative the training data are, the better the accuracy and performance of classification 304.
  • the sleep restriction therapy is a non-pharmacological method that can be used to treat insomnia either alone or in combination with pharmacological treatment. There is a natural tendency among poor sleepers to increase the amount of time spent in bed in an effort to provide more opportunity for sleep, a strategy that is more likely to result in fragmented and poor quality sleep.
  • the sleep restriction therapy consists of curtailing the amount of time spent in bed to the actual amount of time asleep. Time in bed is subsequently adjusted on the basis of the sleep efficiency calculation for a given period of time, which is usually the preceding week. For example, if a person reports sleeping an average of 6 hours per night out of 8 hours spent in bed, the initial prescribed sleep window would be 6 hours.
  • step 401 the medical practitioner initializes wake-up-time and go-to- bed time.
  • step 402 data is collected for five days, which also includes information from questionnaires.
  • step 403 the mean sleep efficiency of the last five days is calculated.
  • 404 a case decision is made, deciding whether the mean sleep efficiency is lower than 80%, 80 to 90% or greater than 90%.
  • step 406 the patient is asked to shorten the time in bed by 15 minutes, in case the mean sleep efficiency is greater than 90 %, in step 405 the patient is asked to prolong time in bed by 15 minutes.
  • step 402 the collection of sleep information for the next five days.
  • step 407 positive feedback is given to the patient and in step 408 the wake -up-time and the go-to-bed time will be kept for one more day and the process continues at step 403.
  • the disclosed concept may also be identified as a system 1000 structured to facilitate cognitive behavioral therapy for a patient having insomnia and may utilize the method set forth below. Prior to discussing the system 1000 and method, the following definitions are noted.
  • unobtrusive sensor means a sensor that is either not attached directly to the patient's body, e.g. by an adhesive, or is wireless.
  • a sensor that is not coupled to the patient's body includes, for example, a ferro-electret foil disposed immediately adjacent, or in contact with, the patient's thorax is an "unobtrusive sensor” because it is not attached to the patient and the patient may move freely.
  • Other “unobtrusive sensors” include a piezoresistive strain gage coupled to the patient's bed, an ECG sensor embedded in fabric, e.g. a pillow, bedding, pajamas, nightcap or a radar/video system structured to detect movement.
  • An "unobtrusive sensor” that may be coupled to the patient's body includes any small/light sensor that may be installed on a bracelet or similar construct.
  • One example of such an unobtrusive sensor is an accelerometer. Any sensor that has a wire extending between the patient and a device is not an “unobtrusive sensor.”
  • “sleeping activity data” is data, and preferably biometric data, representing a measurable action, whether voluntary or involuntary, that is an indication of a patient's state of consciousness, i.e. asleep or awake.
  • the "points" associated with questions (1) and (2) may be combined through simple addition, whereas the "points," e.g. number of cups of coffee consumed, may be a multiplier.
  • the final combined score for an assessment is typically compared to one or more predetermined threshold values associated with that assessment. For example, one assessment may determine the level or severity of the patient's insomnia and another assessment may determine the type of insomnia associated with the patient.
  • Named assessments include, but are not limited to: Epworth Sleepiness Scale (ESS), Pre-Sleep Arousal Scale, Sleep Disturbance Questionnaire, Sleep Hygiene Practice Scale, Caffeine Knowledge Quiz, The Sleep Behavior Self-Rating Scale, The Glasgow Content of Thoughts Inventory, The Glasgow Sleep Effort Scale, Pittsburgh Sleep Quality Index (PSQI), and the Multidimensional Fatigue Inventory (MFI).
  • ESS Epworth Sleepiness Scale
  • Pre-Sleep Arousal Scale Pre-Sleep Arousal Scale
  • Sleep Disturbance Questionnaire Sleep Hygiene Practice Scale
  • Caffeine Knowledge Quiz The Sleep Behavior Self-Rating Scale
  • the Glasgow Content of Thoughts Inventory The Glasgow Sleep Effort Scale, Pittsburgh Sleep Quality Index (PSQI), and the Multidimensional Fatigue Inventory (MFI).
  • PSQI Pittsburgh Sleep Quality Index
  • MFI Multidimensional Fatigue Inventory
  • a “threshold value” may also be a range of values. That is, a
  • threshold value may exist as a maximum value, a minimum value, or a range of (un)acceptable values.
  • the system 1000 structured to facilitate cognitive behavioral therapy for a patient having insomnia includes a communication assembly 1002, a sensor system 1004, a first processing unit 1006, second processing unit 1008, third processing unit 1010, a fourth processing unit 1012, and a display 1014.
  • the communication assembly 1002 is structured to provide for electronic communication between the components identified above. That is, each component is coupled to, and in electrical communication with, the communication assembly 1002.
  • the communication assembly 1002 and the components may be wirelessly coupled to the various components.
  • the communication assembly 1002 is preferably coupled to, and in electrical communication with, an electronic communication network 1001, such as, but not limited to, the Internet.
  • the sensor system 1004 has at least one sensor 1020.
  • the sensor system 1004 is structured to detect sleeping activity data and to provide a sensor system signal incorporating the sleeping activity data.
  • “sleeping activity data” includes at least, heart rate data, respiratory rate data and patient body movement data.
  • data from such sensors 1020 e.g. motion data detected by an actigraph and heart rate data detected by an ECG, may be combined to determine, or estimate, if the patient is awake or asleep.
  • the ECG sensor associated with the disclosed method is an unobtrusive sensor, i.e.
  • sensors that may be used include, but are not limited to inductance plethysmography sensors structured to detect respiratory effort and Emfit foil, structured to measure ballistocardiography (cardiac activity, respiratory activity and body motion activity).
  • the sensor system 1004 that is each at least one sensor 1020, is coupled to, and in electronic communication with, the communication assembly 1002.
  • Each at least one sensor 1020 is an unobtrusive sensor structured to produce a sensor signal having at least one feature, as set forth above.
  • the at least one sensor 1020 may be, but is not limited to, an ECG sensor 1022 and/or an actigraph sensor 1024.
  • the ECG sensor 1022 is structured to detect heart rate data and respiratory rate data.
  • the heart rate data and respiratory rate data being a feature incorporated into an ECG sensor 1022 signal.
  • the actigraph sensor 1024 is structured to detect patient body movement data.
  • the patient body movement data being a feature incorporated into an actigraph sensor 1024 signal. Specific types of the at least one sensor 1020 are discussed above.
  • the at least one sensor 1020 may be a single accelero meter, a single actigraph, etc.
  • Each processing unit i.e. the first, second, third and fourth processing units
  • each processing unit 1006, 1008, 1010, 1012 each include operational elements such as, but not limited to, a programmable logic circuit (PLC) and a communication system (neither shown), as is known in the art.
  • the operational elements of each processing unit 1006, 1008, 1010, 1012 may also include a memory device (not shown) such as, but not limited to, random access memory (RAM), read-only memory (ROM), flash memory, and/or a hard drive, which may be a disk or solid state.
  • the memory device is structured to store one or more sets of executable instructions, hereinafter routines 1030, as well as collected data, other data provided with the routines 1030, and data downloaded via the electronic communication network 1001.
  • any data stored on each processing unit 1006, 1008, 1010, 1012 may be communicated to a remote location, such as, but not limited to a medical professional's office, via the communication assembly 1002 and electronic communication network 1001.
  • data and/or routines 1030 may be downloaded to each processing unit 1006, 1008, 1010, 1012 from a remote location, such as, but not limited to a medical professional's office, via the communication assembly 1002 and electronic communication network 1001. It is understood that the operational elements of each processing unit 1006, 1008, 1010, 1012 operate cooperatively to perform any function that the processing unit is structured to accomplish.
  • each processing unit 1006, 1008, 1010, 1012 are preferably disposed in a housing (shown schematically).
  • the operational elements of two or more processing units 1006, 1008, 1010, 1012 may be disposed in a shared housing (not shown) and may operate cooperatively. That is, for example, routines 1030 for each processing unit 1006, 1008, 1010, 1012 may be stored on a single storage device.
  • At least one processing unit 1006, 1008, 1010, 1012 has a PLC that is not a general purpose PLC.
  • the first processing unit's 1006 PLC is not a general purpose PLC.
  • the first processing unit 1006 corresponds to the pre-processing unit 102 described above. That is, the first processing unit 1006 is structured to perform the steps associated with the pre-processing unit 102 described above.
  • the first processing unit 1006 is coupled to, and in electronic communication with, the communication assembly 1002.
  • the first processing unit 1006 is structured to receive sensor system signal, via the communication assembly 1002, and to convert the sleeping activity data into sleep pattern data.
  • Sleep pattern data includes a patient's time in bed, a patient's total sleep time, a patient's total wake time, a patient's sleep efficiency, a patient's sleep onset latency, a patient's awakenings after sleep onset and a patient's snooze time.
  • time in bed means the time the patient spends in bed, whether asleep or awake.
  • total sleep time is that portion of the time in bed that the patient is asleep.
  • sleep onset latency is the time between the patient getting into bed and first falling asleep.
  • wake after sleep onset is that portion of the time in bed that the patient is awake from the first time he/she fell asleep to the moment he/she finally woke up in the morning.
  • snooze time is the duration from the final awakening to the time when the patient gets out of bed.
  • total wake time is that portion of the time in bed that the patient is awake.
  • the first processing unit 1006 is structured to process the heart rate data, respiratory rate data, and patient body movement data to determine at least one of the patient's time in bed, the patient's total sleep time, the patient's total wake time, the patient's sleep efficiency, the patient's sleep onset latency, the patient's awakenings after sleep onset and the patient's snooze time.
  • the second processing unit 1008 corresponds to the user interface device 107 described above. That is, the second processing unit 1008 is structured to perform the steps associated with the user interface device 107 described above.
  • the second processing unit 1008, preferably, includes the display 1014.
  • the second processing unit 1008 includes a routine 1030 that is structured to present the user interface 108 on the display 1014.
  • the second processing unit 1008, preferably, includes an input assembly 1034 having one or more input devices such as, but not limited to, a keyboard 1036 and a mouse 1038 (or trackball, or touch screen, or any other device that provides a mouse-like functionality).
  • the patient may enter patient input data via the input assembly 1034 and the user interface 108.
  • the user interface 108 is structured to present one or more assessments, discussed below, and to allow the user to input data into a sleep log.
  • the second processing unit 1008 is coupled to, and in electronic communication with, the communication assembly 1002.
  • the third processing unit 1010 corresponds to the feature extraction unit 103, the sleep/wake classifier unit 104 and the sleep efficiency calculation unit 106 described above. That is, the third processing unit 1010 is structured to perform the steps associated with the feature extraction unit 103, the sleep/wake classifier unit 104 and the sleep efficiency calculation unit 106 described above.
  • the third processing unit 1010 is coupled to, and in electronic communication with, the communication assembly 1002.
  • the third processing unit 1010 is structured to receive the sleep pattern data and the patient input data, via the communication assembly 1002, and to perform an analysis thereon. The analysis creates a patient sleep profile.
  • a "patient sleep profile" is a collection of data including objective data, such as the patient body movement data, and subjective data, such as the patient input data.
  • the patient sleep profile includes the patient's sleep history, sleep patterns, qualitative and quantitative measures of insomnia, identification of insomnia-related factors and identification of daytime consequences of insomnia.
  • Daytime consequences of insomnia include, but are not limited to, poor daytime energy, poor cognitive functioning (e.g. concentration, focus, attention, and memory) and poor mood and motivation.
  • a qualitative measure of insomnia includes, but is not limited to, a subjective estimation of sleep quality e.g. poor to excellent or as on a Likert scale of 1 to 10.
  • a quantitative measure of insomnia includes, but is not limited to, the Insomnia Severity Index (ISI) score, discussed in detail below, subjective and objective estimates of Sleep Onset Latency, Wake After Sleep Onset, and Snooze time.
  • ISI Insomnia Severity Index
  • Such quantitative measures of insomnia may be compared to a standard threshold, e.g. the Sleep Onset Latency threshold is set to 30 minutes. Such a comparison may be used to assess the type of sleep disturbance (problem with sleep initiation, sleep maintenance or early awakenings, etc.).
  • subjective and objective estimates of Sleep Efficiency may be compared to standard thresholds (e.g. 90%) to assess whether or not the patient sleeps in a consolidated way.
  • the third processing unit 1010 is structured to send the sleep pattern data, the patient input data and the patient sleep profile to a medical professional via the electronic communications network 1001.
  • the fourth processing unit 1012 corresponds to the sleep restriction algorithm device 106 described above. That is, the fourth processing unit 1012 is structured to perform the steps associated with the sleep restriction algorithm device 106 described above.
  • the fourth processing unit 1012 is coupled to, and in electronic communication with, the communication assembly 1002.
  • the fourth processing unit is structured to analyze the patient sleep profile. The analysis performed by the fourth processing unit 1012 is discussed below.
  • the fourth processing unit 1012 is further structured to provide a course of therapy related to the patient sleep profile. That is, the fourth processing unit 1012 includes a memory device 1050 having stored thereon a plurality of interactive therapeutic instruction modules 1060, 1062, 1064, 1066, 1068, 1070.
  • the therapeutic instruction modules 1060, 1062, 1064, 1066, 1068, 1070 are, generally, associated with insomnia related factors.
  • Insomnia related factors include, but are not limited to behavioral and cognitive factors.
  • behavioral factors include, but are not limited to, sleep restriction, scheduling of bedtime and wake time.
  • Behavioral factors may note a change in the patient's pattern, irregular sleep/wake times and/or when a patient enters in a compensatory strategy, e.g. going to bed earlier and/or sleeping in and/or napping so as to compensate for a bad night's sleep.
  • Behavioral factors also include stimulus control, i.e. association of bed-sleep or when the conditioning between bed and sleep ceases.
  • bed and bedtime become cues for activity rather than cues for sleep.
  • the patient may lie awake in bed, which confuses the connection in the brain between bed and sleep and maintains wakefulness.
  • Other behavioral factors include the patient's pre-sleep routine and other habits that may impact sleep, e.g., alcohol, caffeine, nicotine, dinner habits, bedroom environment, etc.
  • Cognitive factors include, but are not limited to, the patient's mind racing during the night, i.e. hyperarousal at bedtime, and/or worries, anxiety about sleep, e.g., amplification about consequences of insomnia, perceived control and predictability of sleep, unrealistic expectations about sleep.
  • the 1070 contains three parts: (1) therapeutic advice, given on the first day a patient accesses a module, (2) the general information delivered in daily tips on the remaining days of the module, and (3) a goal setting section, accessible on the first day a patient accesses the module.
  • the therapeutic advice consists of recommendations/interventions which are based on the standard CBT-I.
  • the therapeutic advice and daily tips targets those factors that maintain the problems or make them worse by a particular patient and may be related to the goals identified by the patient. That is, while the general, or global, goal is to improve sleep, the patient may know of a specific problem and identify a specific goal related to that problem. For example, the patient may wish to learn to fall asleep more easily and/or learn to fall back to sleep more easily after waking in the middle of the sleep cycle.
  • the patient may wish to learn how to feel more refreshed in the morning, improve their daytime energy, improve their daytime performance, improve their cognitive functioning (concentration, focus, attention and memory) and/or improve their mood and motivation.
  • the patient may wish to identify their actual sleep pattern or determine how many hours of sleep they have during the night.
  • the coaching and/or other advice may be related to the global goal or one or more of the more specific goals.
  • the fourth processing unit 1012 is further structured to organize the selection and order of the therapeutic instruction modules based upon the patient's sleep profile. Finally, the fourth processing unit 1012 is structured to present the organized therapeutic instruction modules on the display 1014.
  • the display 1014 is coupled to, and in electronic communication with, the communication assembly 1002.
  • the display 1014 is structured to present the user interface 108, discussed above, as well as any other information.
  • ISI Insomnia Severity Index
  • IFQ Insomnia Frequency Questionnaire
  • the sleep log includes both questions/statements rated on a scale, and questions/statements to which the response is a time period measured in hours and minutes.
  • the sleep log includes the following questions/statements:
  • the patient may receive cognitive behavioral therapy for insomnia according to a method having the following steps. Initially, the method includes the step of monitoring 2000 a patient's sleep utilizing a sensor system 1004 having at least one unobtrusive sensor 1020. As noted above, the sensor system 1004 is structured to detect sleeping activity data.
  • the method further includes the steps of gathering 2002 patient input data, combining 2006 the patient input data and the sleeping activity data to create a patient sleep profile, analyzing 2008 a patient sleep profile to determine a course of therapy, and presenting 2010 the course of therapy to the patient on a display 1014.
  • the step of monitoring 2000 a patient's sleep utilizing a sensor system having at least one unobtrusive sensor includes the step of utilizing 2020 an ECG sensor and an actigraph sensor.
  • the ECG sensor 1022 is structured to detect heart rate data and respiratory rate data
  • the actigraph sensor 1024 is structured to detect patient body movement data.
  • the step of monitoring 2000 a patient's sleep utilizing a sensor system having at least one unobtrusive sensor further includes the step of processing 2022 the heart rate data, respiratory rate data, and patient body movement data to determine at least one of: the patient's time in bed, the patient's total sleep time, the patient's total wake time, the patient's sleep efficiency, the patient's sleep onset latency, the patient's awakenings after sleep onset and the patient's snooze time.
  • the step of gathering 2002 patient input data includes the steps of: gathering
  • the patient input data is input via the second processing unit 2008 and, more specifically, via the input assembly 1034 and the user interface 108.
  • the step of analyzing 2008 a patient sleep profile to determine a course of therapy may include the steps of: analyzing 2038 the patient input data and the sleeping activity data to identify the factors contributing to the patients insomnia, identifying 2039 the type of insomnia associated with the patient, analyzing 2040 the patient input data and the sleeping activity data to determine the severity of the patient's insomnia, analyzing 2042 the patient input data to determine the severity of the effect of the patient's insomnia on daytime activities, analyzing 2044 the patient input data to determine the type of insomnia suffered by the patient, and, based on the severity of the patient's insomnia, the severity of the effect of the patient's insomnia on daytime activities, and the type of insomnia suffered by the patient, recommending 2046 to the patient one of the following: referral to a medical professional for treatment, recommending an interactive course of therapy to the patient, recommending no treatment.
  • the therapy is, preferably, provided to the patient via the display 1014 which presents the user interface 108. That is, the steps of analyzing 2008 the patient sleep profile to determine a course of therapy and presenting 2010 the course of therapy to the patient on a display 1014 include the steps of: providing 2050 a plurality of interactive therapeutic instruction modules, each module related to an aspect of insomnia, based on the patient sleep profile, determining 2052 which of the interactive therapeutic instruction modules are relevant to the patient's insomnia, determining 2054 the sequence of the interactive therapeutic instruction modules to be presented to the patient, presenting, 2056 in the predetermined sequence, the interactive therapeutic instruction modules to the patient on a display 1014.
  • the plurality of interactive therapeutic instruction modules include a sleep scheduling module 1060, an association bed-sleep module 1062, a cognitive restructuring module 1064, a coping strategy module 1066, a relaxation module 1068, and a lifestyle module 1070.
  • the specific modules each have additional processes as discussed below.
  • the interactive therapeutic instruction modules 1060, 1062, 1064, 1066, 1068, 1070 may be (1) stored on the fourth processing unit 1012, i.e. in the storage device for the fourth processing unit 1012, (2) downloaded to the fourth processing unit 1012 via the electronic communication network 1001 and the communication assembly 1002, or (3) a combination thereof. That is, the fourth processing unit 1012 may store a portion of each interactive therapeutic instruction module 1060, 1062, 1064, 1066, 1068, 1070 and have updates or additional information downloaded as well.
  • the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2060 a sleep scheduling assessment structured to determine a first and a second sleep scheduling score, determining 2062 the patient's first and second sleep scheduling scores, and determining 2064 whether patient has an irregular sleep schedule.
  • the determination 2062 of the patient's first and second sleep scheduling scores may be based on both objective and subjective data.
  • objective data such as, but not limited to, sleep efficiency data collected by the sensors, as discussed above.
  • Subjective data may be based on an assessment such as the following questions/statements:
  • These ratings are converted into the patient's first and second sleep scheduling scores, e.g. by assigning a score to the answer and combining the score with objective data. Based on the factors that are determined, e.g. if patient's first sleep scheduling score is greater than a first sleep scheduling threshold value, the method further includes providing 2066 sleep schedule coaching, and/or, if the patient has an irregular sleep schedule and if patient's second sleep scheduling score is greater than a second sleep scheduling threshold value, providing 2068 sleep schedule coaching. In this module
  • the step of coaching is accomplished by providing information to the patient.
  • the information is provided via the display 1014 and in the form of text messages, e-mail, instant messages, etc.
  • the coaching messages are, preferably, formatted as reminders, suggested therapeutic actions, progress reports, etc., and are typically related to a goal, as discussed above.
  • the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2070 an association bed-sleep assessment structured to determine an association bed-sleep score, determining 2072 the patient's association bed-sleep score, and, if patient's association bed-sleep score is greater than an association bed-sleep threshold value, providing 2074 association bed-sleep coaching.
  • the association bed- sleep assessment may include such questions/statements as:
  • the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2080 a first sleep concept assessment structured to determine a first sleep concept score and determining 2082 the patient's first sleep concept score. If the patient's first sleep concept score is greater than a first sleep concept threshold value, performing 2084 a second sleep concept assessment to determine an amplification score, a perceived control score, and an unrealistic expectation score.
  • Targeted coaching is provided related to any aspect of the sleep concept assessment wherein the patient is over the associated threshold value. That is, if patient's amplification score is greater than an amplification threshold value, providing 2086 amplification coaching.
  • the sleep concept assessment may include such questions/statements as:
  • the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2090 a first coping strategy assessment structured to determine a coping strategy score, determining 2092 a coping strategy score and, if patient's coping strategy score is greater than a coping strategy threshold value, providing 2094 coping strategy coaching.
  • the coping strategy assessment may include such questions/statements as:
  • the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2100 a relaxation assessment structured to determine a transition time score, a worry time score, and a behavioral score, determining 2102 a transition time score, a worry time score, and a behavioral score. If the patient's transition time score is greater than a transition time threshold value, the method includes the step of providing 2104 transition time coaching. If the patient's worry time score is greater than a worry time threshold value, the method includes the step of providing 2106 worry time coaching. If the patient's behavioral score is greater than a behavioral threshold value, the method includes the step of providing 2108 behavioral coaching.
  • the relaxation assessment may include such questions/statements as:
  • the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2110 a lifestyle assessment structured to determine a physical activity score, an alcohol score, a caffeine score, a napping score, a nicotine score, an intake score (i.e. food and/or calorie intake score), and an environment score and determining 2111 a physical activity score, an alcohol score, a caffeine score, a napping score, a nicotine score, an intake score, and an environment score. If the patient's physical activity score is greater than a physical activity threshold value, the method includes the step of providing 2112 physical activity coaching.
  • the method includes the step of providing 2114 alcohol coaching. If the patient's caffeine score is greater than a caffeine threshold value, the method includes the step of providing 2116 caffeine coaching. If the patient's napping score is greater than a napping threshold value, the method includes the step of providing 2118 napping coaching. If the patient's nicotine score is greater than a nicotine threshold value, the method includes the step of providing 2120 nicotine coaching. If the patient's intake score is greater than or less than the intake threshold value (or range), the method includes the step of providing 2122 intake coaching. That is, if the patient is eating too much or too little, the patient will be beyond the intake threshold range. If the patient's environment score is greater than an environment threshold value, the method includes the step of providing 2124 environment coaching.
  • the lifestyle assessment may include, but is not limited to, such questions/statements as:
  • the method is, preferably, an iterative process wherein the patient's sleep profile is updated 2130 so as to reflect the patient's current level of insomnia. While the patient input data and the sleeping activity data may be updated every day, preferably the interactive course of therapy is updated regularly, but less frequently than daily. Preferably, the interactive course of therapy is updated weekly. Once the patient's patient sleep profile has been updated, the step of analyzing 2008 a patient sleep profile to determine a course of therapy is repeated.
  • the step of analyzing 2008 a patient sleep profile to determine a course of therapy may also include the steps of: having 2050 a medical professional review the sleep pattern data, the patient input data and the patient sleep profile, and having 2052 the medical professional provide direct feedback to the patient via the electronic communications network 1001. These steps may be repeated after an update of the sleep pattern data, the patient input data and the patient sleep profile.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Business, Economics & Management (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Educational Administration (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Educational Technology (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Pulmonology (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Tourism & Hospitality (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

The disclosed system and method provide for the automatic assessment of the presence/severity of the sleep problem and its exact nature. The assessment is based on qualitative information about sleep patterns, insomnia-related factors and daytime consequences, as well as quantitative information about sleep patterns measured by a sensor. By combining the different sources of information (subjective as well as objective data), the diagnosis gives more insight into the nature of the sleep problem and is therefore more accurate. Furthermore, the disclosed system may be used to select specific components of the system that are medically relevant to the individual and therefore create a personalized program. The system teaches a selection of self- management skills that could help the individual to better cope with sleep disturbances and target those factors that maintain the problem or make it worse by a particular individual.

Description

METHOD AND SYSTEM FOR PROVIDING BEHAVIOURAL THERAPY FOR
INSOMNIA
[01] This application claims priority under 35 U.S. C. §119(e) to U.S. Provisional
Patent Application Serial No. 61/184,165, filed June 4, 2009 entitled "System and Method for Managing Insomnia."
[02] Field of the Invention
The invention relates to a system and associated method structured to facilitate cognitive behavioral therapy for a patient having insomnia.
[03] Background Information
[04] Sleep disorders are common. At least 10% of the population suffers from a sleep disorder that is clinically significant and of public health importance. Insomnia is by far the most common form of sleep disturbance.
[05] Most insomnia definitions include descriptions of sleep-specific symptoms with associated daytime complaints. Sleep symptoms typically include a difficulty initiating sleep, difficulty maintaining sleep, final awakening that occurs much earlier than desired or sleep that is non-restorative or of generally poor quality. Waking symptoms are associated with daytime complaints related to fatigue, sleepiness, mood disturbance, cognitive difficulties and social or occupational impairment.
[06] The prevalence of isolated insomnia symptoms in the general population is approximately 30 to 50%, and approximately 9 to 15% report significant daytime impairments as a result of chronic insomnia problems. In a majority of the patient population, insomnia is treated by medication. The market for sleeping pills is about 4.6B US$. Other forms of treatment such as sleep restriction therapy are less wide-spread although evidence suggests that they are more effective on the long run than pharmaceutical treatment alone.
[07] A standard diagnostic method for assessing the nature and the severity of the sleep problem, a so-called sleep log or sleep diary, i.e. a questionnaire usually on paper, is used in most cases; also an actigraph can be used as an alternative to a sleep log. [08] The main drawback of this sleep log is that its accuracy is affected by a subjective bias of the patient, e.g. for patients it is often difficult to remember sleep and wake periods during the night correctly.
[09] An automatic detection of sleep and wake stages requires the measurement of vital body signs, but unfortunately most of the existing solutions rely on adhesive electrodes, e.g. by sticking or gluing them to the patient's skin to wear electrodes, e.g. for EEG on the head. Those electrodes are obtrusive to the patient during sleeping due to the cables and recording devices, which are connected to those sensors. Additionally, there is a problem that during resting time, cables or electrodes might loose the connection, which lowers the quality of the received signal.
[10] The diagnosis of insomnia with an automatic sleep log in a fully equipped sleep laboratory is expensive, places are not available over long time duration and thus ability for diagnosis for insomnia patients are limited.
[11] Further, additional sensors and cabling along the patient may disturb the patient's sleep, and therefore influence the evaluation of sleep and wake stages during the night time, which leads to an influence on the sleep records and might lead to a wrong diagnosis.
[12] U.S. Patent Application Publication No. 2004/0225179 discloses automated behavioral methods and systems for treating insomnia that use passive means for determining wake/sleep states and is incorporated herein by reference.
[13] Insomnia is a prevalent sleep disturbance in the general population. However, in practice, patients tend to not seek treatment or are diagnosed by a non sleep specialist, e.g. a GP, without the use of a standard and proper method for assessing the nature and the severity of the sleep problem. This usually results in the underestimation of the reality of the sleep problem and/or the prescription of sleeping pills, although a drug-free therapy - the cognitive behavioural therapy for insomnia (CBT-I) - has been shown to be as effective and more sustainable. Further, a more accurate assessment and a tailored therapy may lead to a higher compliance and consequently to a better medical outcome. [14] An object of the disclosed concept is to provide a system structured to facilitate cognitive behavioral therapy for a patient having insomnia, the system including a communication assembly structured to provide for electronic communication, a sensor system having at least one sensor, the sensor system structured to detect sleeping activity data and to provide a sensor system signal incorporating the sleeping activity data, the sensor system coupled to, and in electronic communication with, the communication assembly, a first processing unit coupled to, and in electronic communication with, the communication assembly, the first processing unit structured to receive the sensor system signal and to convert the sleeping activity data into sleep pattern data, a second processing unit having an input assembly and structured to gather patient input data, the second processing unit coupled to, and in electronic communication with, the communication assembly, a third processing unit coupled to, and in electronic communication with, the communication assembly, the third processing unit structured to receive the sleep pattern data and the patient input data, perform an analysis thereon thereby creating a patient sleep profile, a fourth processing unit coupled to, and in electronic communication with, the communication assembly, the fourth processing unit structured to analyze the patient sleep profile and to provide a course of therapy related to the patient sleep profile, and a display coupled to, and in electronic communication with, the communication assembly, the display structured to present a user interface.
[15] A further object of the disclosed concept is to provide a method of providing cognitive behavioral therapy for insomnia, the method including the steps of monitoring a patient's sleep utilizing a sensor system having at least one unobtrusive sensor, the sensor system structured to detect sleeping activity data, gathering patient input data, combining the patient input data and the sleeping activity data to create a patient sleep profile, analyzing a patient's sleep profile to determine a course of therapy, and presenting the course of therapy to the patient on a display.
[16] As used herein, the term "patient" does not only apply on human beings, but also on animals. Further, the term "patient" does not mean that the respective person/animal is disease ridden, thus, also healthy people will be referred to as "patients." [17] The term "sleep/wake classification" refers to the classification of the epoch of interest as "wake" or "sleep," resulting from the probability of belonging to the respective class, or the classification "true" or "false" given as an output of the classifier but also refers to the display of the classifier results on a user interface or any device.
[18] Additionally, the term "pNN50" refers to the percentage of the number of interval differences of adjacent NN-Intervals greater than 50 ms, the term "SDNN" refers to the standard deviation of all NN-Intervals, the term "SDSD" refers to the Standard deviation between distances between adjacent intervals, the term "RR mean" refers to mean duration of the RR-Intervals, the term "HR mean" refers to the mean heart rate, the term "LF" refers to the low frequency range, as defined by heart rate variability standards, the term "HF" refers to the high frequency range, as defined by heart rate variability standards, the term "RMSSD" refers to root mean square successive differences, and the term "HRV" refers to heart rate variability.
[19] These and other aspects of the invention will be apparent from and elucidated with reference to the embodiments described hereinafter.
[20] In the drawings:
[21] Fig. 1 schematically shows the general principle of the invention;
[22] Fig. 2 shows a schematic flowchart of the feature extraction method of a first preferred embodiment of the invention;
[23] Fig. 3 shows a schematic flowchart of the sleep/wake classification method of a first preferred embodiment of the invention;
[24] Fig. 4 shows the sleep restriction algorithm based on the method of the present invention;
[25] Fig. 5 schematically shows the elements of the invention;
[26] Fig. 6 shows a schematic flowchart of the method of providing cognitive behavioral therapy for insomnia;
[27] Fig. 7 shows a schematic flowchart related to the sleep scheduling module;
[28] Fig. 8 shows a schematic flowchart related to the association bed-sleep module;
[29] Fig. 9 shows a schematic flowchart related to the cognitive restructuring module; [30] Fig. 10 shows a schematic flowchart related to the coping strategy module;
[31] Fig. 11 shows a schematic flowchart related to the relaxation module; and
[32] Fig. 12 shows a schematic flowchart related to the lifestyle module.
[33] As can be seen from Figure 1, the system for sleep/wake classification 100 according to the preferred embodiment of the present invention comprises unobtrusive in- bed sensors for vital body sign monitoring 101 of the heart activity from the ECG, and/or the body movements from a bed foil sensor or the like as will be described in the following. A further step is the pre-processing unit 102 for filtering and artifact removal during preparation of the signals, a feature extraction unit 103 extracting in particular features from the ECG and/or the body movements signal alone or in combination, then there is a sleep/wake classifier unit 104 for classification of the sleep /wake status according to all the input features, sleep efficiency calculation unit 105 for calculating the time asleep compared to the time in bed, used as input for the patient sleep restriction algorithm, device 106 providing, for example, rules for a healthier sleep to the patient.
[34] The output of the sleep/wake classification 104, sleep efficiency calculation 105 and sleep restriction algorithm device 106 can be used to provide feedback to the patient 107 or to the medical professional, who could also get information from additional sources like the sleep log questions for subjective parameters 109.
[35] As for the sensor part of the proposed system, the following embodiments are possible: The sensor is a ferro-electret foil placed underneath the patient's thorax to measure heart rate, respiration and body movements.
[36] Alternatively, in another preferred embodiment a piezo-resistive strain gauge glued onto a slat underneath the mattress in the patient's thorax region can be used to measure heart rate, respiration and body movements.
[37] In another preferred embodiment only an ECG would be used, preferably a textile ECG integrated as a pillow and foot mat electrode in the bed.
[38] Instead of the ferro-electret foil or the strain gauge, the ECG sensor could be combined with a respiration signal, measured with a standard (inductive or piezo- resistive) band around the thorax and/or the abdomen. This type of sensor can be also integrated into textiles (e.g. a T-shirt) to make it more unobtrusive.
[39] Alternatively, in another embodiment instead of the ferro-electret foil or the strain gauge, the ECG sensor could be combined with an accelerometer signal. The device can be a wrist-worn device, but preferably a 2D or 3D accelerometer is placed on the patient's trunk to measure body movements. Also, this type of sensor can be integrated into textiles (e.g. a T-shirt) to make it more unobtrusive. [40] The processing unit comprises several steps as can be seen in Figure 1. These are the preprocessing of the raw data, feature extraction and the sleep/wake classification. In the following paragraphs the different alternatives for each of these steps will be described in more detail.
[41] The signal pre-processing device 102 of Figure 1 includes one or more of the following steps which can be passed through serially, parallel or repeatedly: appropriate filtering of the signal(s); and artifact removal.
In case of an ECG signal, the removal of ectopic beats can be necessary.
In case of gaps in the signal, interpolation might be necessary.
[42] The feature extraction device 103 includes extraction of features from the ECG and a respiration signal comprising:
From the ECG, the following features are derived: statistical heart rate variability parameters from the time domain (e.g. mean heart rate, SDNN, RMSSD etc.); parameters from the heart rate variability (HRV) spectrum (e.g. LF, HF); multi-scale sample entropy; and progressive detrended fluctuation analysis.
[43] From the respiration signal-measured by the ferro-electret foil, the slat sensor or the inductive/piezo-resistive band - the spectrum is calculated and the LF and HF power are extracted as features. In addition, the mean breathing rate is determined. [44] Further, the feature extraction device 103 allows in case of both, the ECG signal and a respiration signal are available, to calculate the coherent power of both spectra as an additional feature. Moreover, the ratio of heart rate and breathing rate can be derived as an additional feature.
[45] Furthermore, from the ferro-electret foil or the slat sensor signal, an activity index is derived based on large body movements.
[46] The preferred embodiment of the present invention further suggests that for the next step - the sleep/wake classification 104 - the activity index and at least one additional feature relating to the cardiac and/or respiratory status are a preferable combination as input for the classification process.
[47] A vector, of at least one feature, and preferably all or at least a sub-set of the above-mentioned features is generated for each epoch of interest, e.g. each 1 -minute segment of data.
[48] Further, this vector is fed into a sleep/wake classifier 104 which is based on a standard pattern recognition approach with supervised learning, as will be described in Figure 3. For the classifier, the following approaches can preferably be used: Bayesian linear or quadratic discriminant classifier; support vector machine; k-Nearest-Neighbour (kNN) method; Neural Network; and Hidden Markov Model.
[49] The parameters of the classifier are trained on a large database of representative data.
[50] In order to receive the patient's input regarding the subjective questions in the sleep log, Insomnia Severity Index, Insomnia Frequency Questionnaire, or other assessments and to give feedback to him, the input unit and the display unit are preferably combined in the preferred embodiment of the present invention in one user interface device 107. This device can be a normal laptop PC, a tablet PC with a touch screen, a handheld device such as a PDA or a mobile phone. Depending on the processing power of this device, the processing unit can also be part of this device. The feedback to the patient can contain one or more of the following parameters: time in bed, total sleep time, total wake time, sleep efficiency, sleep latency, number and durations of awakenings, or a simplified hypnogram.
[51] The feedback to the medical professional can be given via the same user interface 108. In another embodiment, there is a download procedure to transfer the patient's data from the patient user interface to the physician's PC (e.g. via a USB cable, via Bluetooth, ZigBee or any other communication standard or device). In yet another embodiment, the patient's data can be (automatically) sent to the physician via the Internet or GSM, UMTS, EDGE, GPRS, or any other Internet or mobile phone standard or system.
[52] The feedback to the medical professional should contain all of the above- mentioned parameters. Furthermore, it should also contain the patient's answers to the subjective sleep log questions so that he can compare the subjective and objective data which gives him important information for the appropriate therapy approach. This is, for example, especially important in case of sleep-state misperception, a type of insomnia where objective sleep data reflect a normal sleep pattern but the patient himself does not recognize that he has slept.
[53] As can be seen in Figure 2, the ECG signal provided by an ECG sensor 200 undergoes a pre-processing 201, wherein the preprocessing consists in R-peak detection, ectopic beat removal, linear interpolation and resampling at a predefined frequency, preferably at 4 Hz. The resulting RR-interval series is then considered and heart rate variability parameters, according to the standard, are assessed in frequency and time domains. First the power spectrum calculation 202 over a predefined time period, preferably a 5-minute segment of the time series, centered on the one-minute epoch of interest, is computed using preferably an autoregressive model with advanced detrending. Alternatively, other methods based on Fourier analysis, time-frequency distributions, time -varying autoregressive modeling is available. In the two last cases, the power spectral estimation is updated on a shorter time scale, e.g. every new detected R-peak of the ECG.
[54] The power spectrum in the low-frequency band LF preferably at 0.04-0.15 Hz and in the high frequency band HF preferably at 0.15-0.4 Hz are used to define the spectral features in 203: the power is normalized according to LF_norm=LF/(LF+HF) and LF/HF ratio is calculated. Furthermore, the RR-interval series time statistics over a predefined time period, preferably a 5-minute segment, in 204 provides the resulting time domain features in 205, e.g. pNN50 (percentage of the number of interval differences of adjacent NN-Intervals greater than 50 ms ), SDNN (standard deviation of all NN- Intervals), SDSD (standard deviation of successive differences between adjacent intervals), RMSSD (root mean square successive differences), RR mean (mean duration of the RR-Intervals ) and HR mean (mean of the instantaneous heart rate).
[55] Non-linear parameters are also extracted from the RR-interval time series in 206 by the application of two methods. The first non-linear calculation method used in 207 is progressive detrended fluctuation analysis which allows to gradually integrate the signal before detrending over windows of length 64. Further, the partial sums of the squared signal are then considered and this provides the resulting differentiated time series in 208 from which we extract a new feature 209, defined as the maximum value over the considered epoch, preferably a one-minute epoch but which can be any predefined epoch duration.
[56] The second non-linear calculation method applied to the RR-interval series provides the multiscale sample entropy. Firstly, the series is coarse-grained at scales 1 and 2 in 210 and 5-minute segments are considered. The sample entropy (hereafter called sampen) is calculated in 211 at several levels from 1 to 10 Hence, the following features in 212 are provided: sampen_scalel_k, for levels k=l to 10 and sampen_scale2_k, for levels k=l to 10.
[57] As can be seen in the lower part of Figure 2, the bed foil signal provided by bed foil sensor 213 is undergoing a pre-processing 214 which consists of noise reduction and calibration. The use of low pass filtering 215 leads to the breathing signal. Peak identification on this signal allows to deduce the breath interval series, which is also linearly interpolated and resampled at a predefined rate, preferably at 4 Hz in 216. The power spectrum 217 is computed using preferably an autoregressive model with advanced detrending. The power spectrum is then split and normalized in 218 in the low- frequency band LF (0.04-0.15 Hz) and in the high frequency band HF (0.15-0.4 Hz), which are used to define the spectral features LF norm respi and LF/HF ratio respi. Besides, the detection of small and large energy artefacts in 219 allows to define a heuristic activity index over one-minute epochs, also used as a feature in 220. Further, the band-pass filtering in 221 delivers the so-called ballistocardiogram, which represents the mechanical heart activity. This signal could be an interesting alternative to the ECG signal to get the heart rate variability signal. Finally, the RR-interval and the breath interval series are combined in 222 by estimating the squared coherence function over 5- minute epochs centred on the one-minute epoch of interest. This coherence function is multiplied by the autospectrum of the RR-interval series and integrated along the frequency axis. The resulting feature in 223 is the amount of coherent power in %. We could also think of other features assessing the cardiopulmonary coupling, like the RR- interval/breath interval ratio.
[58] As can be seen in the right part of Figure 2, a preferred embodiment contains the features 203, 205, 209, 212, 223, 218, 220, which form the components of the feature vector used in the classification process which is further described in Figure 3.
[59] Figure 3 is a preferred embodiment of the method for sleep/wake classification.
Step 303 represents information coming from the feature extraction process providing a vector with at least one element, which belongs to the test data set. The decision is based on a supervised learning classifier 301, which is trained with a training data set 302. The classifier 304 decides on the basis of a Bayesian linear or quadratic discriminant classifier, a support vector machine or the k-Nearest-Neighbour (kNN) classifier and with a supervised learning approach based on the training data set, whether the patient is awake or asleep. The more representative the training data are, the better the accuracy and performance of classification 304.
[60] The sleep restriction therapy is a non-pharmacological method that can be used to treat insomnia either alone or in combination with pharmacological treatment. There is a natural tendency among poor sleepers to increase the amount of time spent in bed in an effort to provide more opportunity for sleep, a strategy that is more likely to result in fragmented and poor quality sleep. [61] The sleep restriction therapy consists of curtailing the amount of time spent in bed to the actual amount of time asleep. Time in bed is subsequently adjusted on the basis of the sleep efficiency calculation for a given period of time, which is usually the preceding week. For example, if a person reports sleeping an average of 6 hours per night out of 8 hours spent in bed, the initial prescribed sleep window would be 6 hours.
[62] The subsequent allowable time in bed by about 15 to 20 minutes for a given week when sleep efficiency exceeds 90%, decreased by the same amount of time when the sleep efficiency is lower than 80% and kept stable when the sleep efficiency falls between 80 and 90%. Alternatively, a therapist may set the upper limit at 85% sleep efficiency. Adjustments are made periodically, for example weekly, until optimal sleep duration is achieved. Variations in implementing this procedure may involve changing the time in bed on the basis of a moving average of the sleep efficiency, for example, of the past three to five days, or changing it on a weekly basis regardless of change of the sleep efficiency. This procedure improves sleep continuity through a mild sleep deprivation and a reduction of sleep anticipatory anxiety. To prevent excessive daytime sleepiness, the time in bed should not be reduced to less than five hours per night.
[63] As can be seen in Figure 4, there is a preferred embodiment of the sleep restriction therapy method based on the sleep efficiency calculation which is provided by the present invention.
[64] In the first step 401 , the medical practitioner initializes wake-up-time and go-to- bed time. In step 402 data is collected for five days, which also includes information from questionnaires.
[65] In step 403 the mean sleep efficiency of the last five days is calculated. In step
404 a case decision is made, deciding whether the mean sleep efficiency is lower than 80%, 80 to 90% or greater than 90%.
[66] In case the mean sleep efficiency is lower than 80%, in step 406, the patient is asked to shorten the time in bed by 15 minutes, in case the mean sleep efficiency is greater than 90 %, in step 405 the patient is asked to prolong time in bed by 15 minutes. The process recontinues at step 402 with the collection of sleep information for the next five days. In case the mean sleep efficiency is between 80 to 90%, in step 407 positive feedback is given to the patient and in step 408 the wake -up-time and the go-to-bed time will be kept for one more day and the process continues at step 403.
[67] The disclosed concept may also be identified as a system 1000 structured to facilitate cognitive behavioral therapy for a patient having insomnia and may utilize the method set forth below. Prior to discussing the system 1000 and method, the following definitions are noted.
[68] As used herein, "unobtrusive sensor" means a sensor that is either not attached directly to the patient's body, e.g. by an adhesive, or is wireless. A sensor that is not coupled to the patient's body includes, for example, a ferro-electret foil disposed immediately adjacent, or in contact with, the patient's thorax is an "unobtrusive sensor" because it is not attached to the patient and the patient may move freely. Other "unobtrusive sensors" include a piezoresistive strain gage coupled to the patient's bed, an ECG sensor embedded in fabric, e.g. a pillow, bedding, pajamas, nightcap or a radar/video system structured to detect movement. An "unobtrusive sensor" that may be coupled to the patient's body includes any small/light sensor that may be installed on a bracelet or similar construct. One example of such an unobtrusive sensor is an accelerometer. Any sensor that has a wire extending between the patient and a device is not an "unobtrusive sensor."
[69] As used herein, "sleeping activity data" is data, and preferably biometric data, representing a measurable action, whether voluntary or involuntary, that is an indication of a patient's state of consciousness, i.e. asleep or awake.
[70] As used herein, an "assessment" is one or more questions/statements answered on a scale, e.g. 1 to 5, days per week, very sleepy to wide awake, etc. Such answers are converted to "points," e.g. sleepy = 1 point, wide awake = 5 points. If more than one question is related, the points may be combined into a score. The act of combining points may be simple addition, but may also include a multiplier for synergistic combinations. For example, an assessment may include the following three questions/statements: Rate the severity of (1) difficulty falling asleep, 1 = none, 5 = severe, (2) difficulty staying asleep, 1 = none, 5 = severe, and (3) how many cups of coffee do you drink after 6:00
PM. Here, the "points" associated with questions (1) and (2) may be combined through simple addition, whereas the "points," e.g. number of cups of coffee consumed, may be a multiplier. Further, as is known, the final combined score for an assessment is typically compared to one or more predetermined threshold values associated with that assessment. For example, one assessment may determine the level or severity of the patient's insomnia and another assessment may determine the type of insomnia associated with the patient. Named assessments include, but are not limited to: Epworth Sleepiness Scale (ESS), Pre-Sleep Arousal Scale, Sleep Disturbance Questionnaire, Sleep Hygiene Practice Scale, Caffeine Knowledge Quiz, The Sleep Behavior Self-Rating Scale, The Glasgow Content of Thoughts Inventory, The Glasgow Sleep Effort Scale, Pittsburgh Sleep Quality Index (PSQI), and the Multidimensional Fatigue Inventory (MFI).
[71] As used herein, a "threshold value" may also be a range of values. That is, a
"threshold value" may exist as a maximum value, a minimum value, or a range of (un)acceptable values.
[72] As shown in Figure 5, the system 1000 structured to facilitate cognitive behavioral therapy for a patient having insomnia includes a communication assembly 1002, a sensor system 1004, a first processing unit 1006, second processing unit 1008, third processing unit 1010, a fourth processing unit 1012, and a display 1014. The communication assembly 1002 is structured to provide for electronic communication between the components identified above. That is, each component is coupled to, and in electrical communication with, the communication assembly 1002. The communication assembly 1002 and the components may be wirelessly coupled to the various components. The communication assembly 1002 is preferably coupled to, and in electrical communication with, an electronic communication network 1001, such as, but not limited to, the Internet.
[73] The sensor system 1004 has at least one sensor 1020. The sensor system 1004 is structured to detect sleeping activity data and to provide a sensor system signal incorporating the sleeping activity data. As used herein, "sleeping activity data" includes at least, heart rate data, respiratory rate data and patient body movement data. As is known, data from such sensors 1020, e.g. motion data detected by an actigraph and heart rate data detected by an ECG, may be combined to determine, or estimate, if the patient is awake or asleep. It is again noted that the ECG sensor associated with the disclosed method is an unobtrusive sensor, i.e. a sensor incorporated into the patient's clothes rather than a traditional ECG having wires/leads coupled to a sensor adhered to the patient's skin. Other sensors that may be used include, but are not limited to inductance plethysmography sensors structured to detect respiratory effort and Emfit foil, structured to measure ballistocardiography (cardiac activity, respiratory activity and body motion activity).
[74] The sensor system 1004, that is each at least one sensor 1020, is coupled to, and in electronic communication with, the communication assembly 1002. Each at least one sensor 1020 is an unobtrusive sensor structured to produce a sensor signal having at least one feature, as set forth above. The at least one sensor 1020 may be, but is not limited to, an ECG sensor 1022 and/or an actigraph sensor 1024. The ECG sensor 1022 is structured to detect heart rate data and respiratory rate data. The heart rate data and respiratory rate data being a feature incorporated into an ECG sensor 1022 signal. The actigraph sensor 1024 is structured to detect patient body movement data. The patient body movement data being a feature incorporated into an actigraph sensor 1024 signal. Specific types of the at least one sensor 1020 are discussed above. Thus, the at least one sensor 1020 may be a single accelero meter, a single actigraph, etc.
[75] Each processing unit, i.e. the first, second, third and fourth processing units
1006, 1008, 1010, 1012, each include operational elements such as, but not limited to, a programmable logic circuit (PLC) and a communication system (neither shown), as is known in the art. The operational elements of each processing unit 1006, 1008, 1010, 1012 may also include a memory device (not shown) such as, but not limited to, random access memory (RAM), read-only memory (ROM), flash memory, and/or a hard drive, which may be a disk or solid state. The memory device is structured to store one or more sets of executable instructions, hereinafter routines 1030, as well as collected data, other data provided with the routines 1030, and data downloaded via the electronic communication network 1001. As is known, any data stored on each processing unit 1006, 1008, 1010, 1012 may be communicated to a remote location, such as, but not limited to a medical professional's office, via the communication assembly 1002 and electronic communication network 1001. Similarly, data and/or routines 1030 may be downloaded to each processing unit 1006, 1008, 1010, 1012 from a remote location, such as, but not limited to a medical professional's office, via the communication assembly 1002 and electronic communication network 1001. It is understood that the operational elements of each processing unit 1006, 1008, 1010, 1012 operate cooperatively to perform any function that the processing unit is structured to accomplish.
[76] The operational elements of each processing unit 1006, 1008, 1010, 1012 are preferably disposed in a housing (shown schematically). The operational elements of two or more processing units 1006, 1008, 1010, 1012 may be disposed in a shared housing (not shown) and may operate cooperatively. That is, for example, routines 1030 for each processing unit 1006, 1008, 1010, 1012 may be stored on a single storage device. At least one processing unit 1006, 1008, 1010, 1012, however, has a PLC that is not a general purpose PLC. Preferably, the first processing unit's 1006 PLC is not a general purpose PLC.
[77] The first processing unit 1006 corresponds to the pre-processing unit 102 described above. That is, the first processing unit 1006 is structured to perform the steps associated with the pre-processing unit 102 described above. The first processing unit 1006 is coupled to, and in electronic communication with, the communication assembly 1002. The first processing unit 1006 is structured to receive sensor system signal, via the communication assembly 1002, and to convert the sleeping activity data into sleep pattern data. Sleep pattern data includes a patient's time in bed, a patient's total sleep time, a patient's total wake time, a patient's sleep efficiency, a patient's sleep onset latency, a patient's awakenings after sleep onset and a patient's snooze time. As used herein, "time in bed" means the time the patient spends in bed, whether asleep or awake. As used herein, "total sleep time" is that portion of the time in bed that the patient is asleep. As used herein, "sleep onset latency" is the time between the patient getting into bed and first falling asleep. As used herein, "wake after sleep onset" is that portion of the time in bed that the patient is awake from the first time he/she fell asleep to the moment he/she finally woke up in the morning. As used herein, "snooze time" is the duration from the final awakening to the time when the patient gets out of bed. As used herein, "total wake time" is that portion of the time in bed that the patient is awake. As used herein, "sleep efficiency" is the ratio of total sleep time to time in bed. As used herein, "awakenings after sleep onset" is the number of times that the patient wakes after first falling asleep. Thus, the first processing unit 1006 is structured to process the heart rate data, respiratory rate data, and patient body movement data to determine at least one of the patient's time in bed, the patient's total sleep time, the patient's total wake time, the patient's sleep efficiency, the patient's sleep onset latency, the patient's awakenings after sleep onset and the patient's snooze time.
[78] The second processing unit 1008 corresponds to the user interface device 107 described above. That is, the second processing unit 1008 is structured to perform the steps associated with the user interface device 107 described above. The second processing unit 1008, preferably, includes the display 1014. The second processing unit 1008 includes a routine 1030 that is structured to present the user interface 108 on the display 1014. The second processing unit 1008, preferably, includes an input assembly 1034 having one or more input devices such as, but not limited to, a keyboard 1036 and a mouse 1038 (or trackball, or touch screen, or any other device that provides a mouse-like functionality). As is known, the patient may enter patient input data via the input assembly 1034 and the user interface 108. The user interface 108 is structured to present one or more assessments, discussed below, and to allow the user to input data into a sleep log. The second processing unit 1008 is coupled to, and in electronic communication with, the communication assembly 1002.
[79] The third processing unit 1010 corresponds to the feature extraction unit 103, the sleep/wake classifier unit 104 and the sleep efficiency calculation unit 106 described above. That is, the third processing unit 1010 is structured to perform the steps associated with the feature extraction unit 103, the sleep/wake classifier unit 104 and the sleep efficiency calculation unit 106 described above. The third processing unit 1010 is coupled to, and in electronic communication with, the communication assembly 1002. The third processing unit 1010 is structured to receive the sleep pattern data and the patient input data, via the communication assembly 1002, and to perform an analysis thereon. The analysis creates a patient sleep profile. As used herein, a "patient sleep profile" is a collection of data including objective data, such as the patient body movement data, and subjective data, such as the patient input data. The patient sleep profile includes the patient's sleep history, sleep patterns, qualitative and quantitative measures of insomnia, identification of insomnia-related factors and identification of daytime consequences of insomnia. Daytime consequences of insomnia include, but are not limited to, poor daytime energy, poor cognitive functioning (e.g. concentration, focus, attention, and memory) and poor mood and motivation.
[80] A qualitative measure of insomnia includes, but is not limited to, a subjective estimation of sleep quality e.g. poor to excellent or as on a Likert scale of 1 to 10. A quantitative measure of insomnia includes, but is not limited to, the Insomnia Severity Index (ISI) score, discussed in detail below, subjective and objective estimates of Sleep Onset Latency, Wake After Sleep Onset, and Snooze time. Such quantitative measures of insomnia may be compared to a standard threshold, e.g. the Sleep Onset Latency threshold is set to 30 minutes. Such a comparison may be used to assess the type of sleep disturbance (problem with sleep initiation, sleep maintenance or early awakenings, etc.). Further, subjective and objective estimates of Sleep Efficiency, may be compared to standard thresholds (e.g. 90%) to assess whether or not the patient sleeps in a consolidated way.
[81] The third processing unit 1010 is structured to send the sleep pattern data, the patient input data and the patient sleep profile to a medical professional via the electronic communications network 1001.
[82] The fourth processing unit 1012 corresponds to the sleep restriction algorithm device 106 described above. That is, the fourth processing unit 1012 is structured to perform the steps associated with the sleep restriction algorithm device 106 described above. The fourth processing unit 1012 is coupled to, and in electronic communication with, the communication assembly 1002. The fourth processing unit is structured to analyze the patient sleep profile. The analysis performed by the fourth processing unit 1012 is discussed below. The fourth processing unit 1012 is further structured to provide a course of therapy related to the patient sleep profile. That is, the fourth processing unit 1012 includes a memory device 1050 having stored thereon a plurality of interactive therapeutic instruction modules 1060, 1062, 1064, 1066, 1068, 1070.
[83] The therapeutic instruction modules 1060, 1062, 1064, 1066, 1068, 1070 are, generally, associated with insomnia related factors. Insomnia related factors include, but are not limited to behavioral and cognitive factors. For example, behavioral factors include, but are not limited to, sleep restriction, scheduling of bedtime and wake time. Behavioral factors may note a change in the patient's pattern, irregular sleep/wake times and/or when a patient enters in a compensatory strategy, e.g. going to bed earlier and/or sleeping in and/or napping so as to compensate for a bad night's sleep. Behavioral factors also include stimulus control, i.e. association of bed-sleep or when the conditioning between bed and sleep ceases. That is, bed and bedtime become cues for activity rather than cues for sleep. For example, the patient may lie awake in bed, which confuses the connection in the brain between bed and sleep and maintains wakefulness. Other behavioral factors include the patient's pre-sleep routine and other habits that may impact sleep, e.g., alcohol, caffeine, nicotine, dinner habits, bedroom environment, etc. Cognitive factors include, but are not limited to, the patient's mind racing during the night, i.e. hyperarousal at bedtime, and/or worries, anxiety about sleep, e.g., amplification about consequences of insomnia, perceived control and predictability of sleep, unrealistic expectations about sleep.
[84] Each interactive therapeutic instruction module 1060, 1062, 1064, 1066, 1068,
1070 contains three parts: (1) therapeutic advice, given on the first day a patient accesses a module, (2) the general information delivered in daily tips on the remaining days of the module, and (3) a goal setting section, accessible on the first day a patient accesses the module. The therapeutic advice consists of recommendations/interventions which are based on the standard CBT-I. The therapeutic advice and daily tips targets those factors that maintain the problems or make them worse by a particular patient and may be related to the goals identified by the patient. That is, while the general, or global, goal is to improve sleep, the patient may know of a specific problem and identify a specific goal related to that problem. For example, the patient may wish to learn to fall asleep more easily and/or learn to fall back to sleep more easily after waking in the middle of the sleep cycle. Alternatively, the patient may wish to learn how to feel more refreshed in the morning, improve their daytime energy, improve their daytime performance, improve their cognitive functioning (concentration, focus, attention and memory) and/or improve their mood and motivation. Or, as another alternative, the patient may wish to identify their actual sleep pattern or determine how many hours of sleep they have during the night. The coaching and/or other advice may be related to the global goal or one or more of the more specific goals.
[85] The fourth processing unit 1012 is further structured to organize the selection and order of the therapeutic instruction modules based upon the patient's sleep profile. Finally, the fourth processing unit 1012 is structured to present the organized therapeutic instruction modules on the display 1014.
[86] The display 1014 is coupled to, and in electronic communication with, the communication assembly 1002. The display 1014 is structured to present the user interface 108, discussed above, as well as any other information.
[87] Prior to discussing the method associated with the system 1000, the following assessments are noted. The assessments, or individual portions thereof, are used during the various analyses discussed below. One known assessment is the Insomnia Severity Index (ISI) which includes the following questions/statements:
[88] Insomnia Severity Index
Figure imgf000022_0001
Figure imgf000023_0001
[89] Another known assessment, the Insomnia Frequency Questionnaire (IFQ), includes responses indicating the number of days per week the patient suffers from the indicated symptoms and includes the following questions/statements:
[90]
Figure imgf000023_0003
Figure imgf000023_0002
[91] The sleep log includes both questions/statements rated on a scale, and questions/statements to which the response is a time period measured in hours and minutes. The sleep log includes the following questions/statements:
[92] Sleep log
Default sleep log (during baseline assessment and program):
1. Please rate the quality of your sleep last night: Using a scale of 1-5, very poor ... excellent
2. How did you feel when you woke up this morning? Using a scale 1-5, exhausted ... refreshed
3. What time did you turn off the light to go to sleep last night? -> Enter time as hh:mm
4. How long did it take you to fall asleep? -> Enter in minutes
5. What was the time when you finally woke up this morning? -^ Enter time as hh:mm
6. Please estimate the total amount of time (in minutes) you spent awake during the night (from the first time you fell asleep to the moment you finally woke up this morning) -^ Enter in minutes
7. What time did you get out of bed this morning? -^ Enter time as hh:mm
8. How tired did you feel yesterday?
Using a scale of 1-5, very tired ... very alert
9. Were there yesterday unusual external factors that may have disrupted your sleep? (e.g. health, work, family, environment, etc.)
Using a scale of 1-5: many disruptive factors ... no disruptive factors Another sleep assessment is the DBAS- 16 which relates to a patient's beliefs about sleep and includes statements which the patient rates such as, but not limited to:
Figure imgf000025_0001
[93] Utilizing the system 1000 structured to facilitate cognitive behavioral therapy for a patient having insomnia the patient may receive cognitive behavioral therapy for insomnia according to a method having the following steps. Initially, the method includes the step of monitoring 2000 a patient's sleep utilizing a sensor system 1004 having at least one unobtrusive sensor 1020. As noted above, the sensor system 1004 is structured to detect sleeping activity data. The method further includes the steps of gathering 2002 patient input data, combining 2006 the patient input data and the sleeping activity data to create a patient sleep profile, analyzing 2008 a patient sleep profile to determine a course of therapy, and presenting 2010 the course of therapy to the patient on a display 1014.
[94] The step of monitoring 2000 a patient's sleep utilizing a sensor system having at least one unobtrusive sensor includes the step of utilizing 2020 an ECG sensor and an actigraph sensor. As noted above, the ECG sensor 1022 is structured to detect heart rate data and respiratory rate data and the actigraph sensor 1024 is structured to detect patient body movement data. The step of monitoring 2000 a patient's sleep utilizing a sensor system having at least one unobtrusive sensor further includes the step of processing 2022 the heart rate data, respiratory rate data, and patient body movement data to determine at least one of: the patient's time in bed, the patient's total sleep time, the patient's total wake time, the patient's sleep efficiency, the patient's sleep onset latency, the patient's awakenings after sleep onset and the patient's snooze time.
[95] The step of gathering 2002 patient input data includes the steps of: gathering
2030 data on the patient's sleep history, gathering 2032 data on the patient's medical history, having 2034 the patient complete an insomnia severity index assessment, and having 2036 the patient maintain a sleep log. As noted above, the patient input data is input via the second processing unit 2008 and, more specifically, via the input assembly 1034 and the user interface 108.
[96] The step of analyzing 2008 a patient sleep profile to determine a course of therapy may include the steps of: analyzing 2038 the patient input data and the sleeping activity data to identify the factors contributing to the patients insomnia, identifying 2039 the type of insomnia associated with the patient, analyzing 2040 the patient input data and the sleeping activity data to determine the severity of the patient's insomnia, analyzing 2042 the patient input data to determine the severity of the effect of the patient's insomnia on daytime activities, analyzing 2044 the patient input data to determine the type of insomnia suffered by the patient, and, based on the severity of the patient's insomnia, the severity of the effect of the patient's insomnia on daytime activities, and the type of insomnia suffered by the patient, recommending 2046 to the patient one of the following: referral to a medical professional for treatment, recommending an interactive course of therapy to the patient, recommending no treatment.
[97] If the patient is recommended an interactive course of therapy, the therapy is, preferably, provided to the patient via the display 1014 which presents the user interface 108. That is, the steps of analyzing 2008 the patient sleep profile to determine a course of therapy and presenting 2010 the course of therapy to the patient on a display 1014 include the steps of: providing 2050 a plurality of interactive therapeutic instruction modules, each module related to an aspect of insomnia, based on the patient sleep profile, determining 2052 which of the interactive therapeutic instruction modules are relevant to the patient's insomnia, determining 2054 the sequence of the interactive therapeutic instruction modules to be presented to the patient, presenting, 2056 in the predetermined sequence, the interactive therapeutic instruction modules to the patient on a display 1014.
[98] As noted above, each interactive therapeutic instruction module 1060, 1062,
1064, 1066, 1068, 1070 contains three parts: (1) therapeutic advice, given on the first day a patient accesses a module, (2) the general information delivered in daily tips on the remaining days of the module, and (3) a goal setting section, accessible on the first day a patient accesses the module. The plurality of interactive therapeutic instruction modules include a sleep scheduling module 1060, an association bed-sleep module 1062, a cognitive restructuring module 1064, a coping strategy module 1066, a relaxation module 1068, and a lifestyle module 1070. In addition to the general information associated with each interactive therapeutic instruction module 1060, 1062, 1064, 1066, 1068, 1070, as discussed above, the specific modules each have additional processes as discussed below.
It is further noted that the interactive therapeutic instruction modules 1060, 1062, 1064, 1066, 1068, 1070 may be (1) stored on the fourth processing unit 1012, i.e. in the storage device for the fourth processing unit 1012, (2) downloaded to the fourth processing unit 1012 via the electronic communication network 1001 and the communication assembly 1002, or (3) a combination thereof. That is, the fourth processing unit 1012 may store a portion of each interactive therapeutic instruction module 1060, 1062, 1064, 1066, 1068, 1070 and have updates or additional information downloaded as well. [99] For example, if the sleep scheduling module 1060 is recommended to the patient, the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2060 a sleep scheduling assessment structured to determine a first and a second sleep scheduling score, determining 2062 the patient's first and second sleep scheduling scores, and determining 2064 whether patient has an irregular sleep schedule. The determination 2062 of the patient's first and second sleep scheduling scores may be based on both objective and subjective data. For example, objective data, such as, but not limited to, sleep efficiency data collected by the sensors, as discussed above. Subjective data may be based on an assessment such as the following questions/statements:
- 1 set myself a regular rising time each morning regardless of my sleep quality and duration (rated from strongly disagree to strongly agree);
- When I don't get proper amount of sleep, on a given night, I need to catch up on the next day by napping or on the next night by sleeping longer (rated from strongly disagree to strongly agree); and
- Rating further translated into a score.
[100] These ratings are converted into the patient's first and second sleep scheduling scores, e.g. by assigning a score to the answer and combining the score with objective data. Based on the factors that are determined, e.g. if patient's first sleep scheduling score is greater than a first sleep scheduling threshold value, the method further includes providing 2066 sleep schedule coaching, and/or, if the patient has an irregular sleep schedule and if patient's second sleep scheduling score is greater than a second sleep scheduling threshold value, providing 2068 sleep schedule coaching. In this module
1060, as well as all other modules 1062, 1064, 1066, 1068, 1070, the step of coaching is accomplished by providing information to the patient. Preferably, the information is provided via the display 1014 and in the form of text messages, e-mail, instant messages, etc. The coaching messages are, preferably, formatted as reminders, suggested therapeutic actions, progress reports, etc., and are typically related to a goal, as discussed above.
[101] If the association bed-sleep module is recommended to the patient, the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2070 an association bed-sleep assessment structured to determine an association bed-sleep score, determining 2072 the patient's association bed-sleep score, and, if patient's association bed-sleep score is greater than an association bed-sleep threshold value, providing 2074 association bed-sleep coaching. The association bed- sleep assessment may include such questions/statements as:
Please indicate how often you do the following things in your bed before falling asleep or while in your bedroom. Complete the form by considering what you would do in an average week: - Watch TV, work, use the PC, listen to the radio or music, have a conversation with someone, speak on the telephone, eat and drink, read a book or magazine: never/rarely/sometimes/often/quite often; - 1 switch the light off as soon as I get into bed: never/rarely/sometimes/often/quite often; and - 1 spend a lot of time lying awake in bed at night: never/ rarely/sometimes/often/quite often which are converted into the patient's association bed-sleep score. [102] If the cognitive restructuring module 1064 is recommended to the patient, the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2080 a first sleep concept assessment structured to determine a first sleep concept score and determining 2082 the patient's first sleep concept score. If the patient's first sleep concept score is greater than a first sleep concept threshold value, performing 2084 a second sleep concept assessment to determine an amplification score, a perceived control score, and an unrealistic expectation score. Targeted coaching is provided related to any aspect of the sleep concept assessment wherein the patient is over the associated threshold value. That is, if patient's amplification score is greater than an amplification threshold value, providing 2086 amplification coaching. If the patient's perceived control score is greater than a perceived control threshold value, providing 2088 perceived control coaching. Further, if a patient's unrealistic expectation score is greater than an unrealistic expectation threshold value, providing 2089 unrealistic expectation coaching. The sleep concept assessment may include such questions/statements as:
Qa: "I put too much effort into sleeping at night when it should come naturally;"
Qb: "I worry about not sleeping if I am in bed at night and cannot sleep;" and
Qc: "I get anxious about sleeping before I go to bed at night" as well as questions from the ISI, the IFQ and the DBAS- 16 which are converted into a the patient's first and second sleep concept scores.
[103] If the coping strategy module is recommended to the patient, the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2090 a first coping strategy assessment structured to determine a coping strategy score, determining 2092 a coping strategy score and, if patient's coping strategy score is greater than a coping strategy threshold value, providing 2094 coping strategy coaching. The coping strategy assessment may include such questions/statements as:
- 1 have little ability to manage the negative consequences of disturbed sleep: never true, seldom true, sometimes true, often true, very often true;
- 1 feel my sleep problems are ruining my ability to enjoy life and prevent me from doing what I want (social/occupational/family obligations); and
- 1 avoid or cancel obligations (social, family) after a poor night's sleep which are converted into the patient's coping strategy score.
[104] If the relaxation module is recommended to the patient, the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2100 a relaxation assessment structured to determine a transition time score, a worry time score, and a behavioral score, determining 2102 a transition time score, a worry time score, and a behavioral score. If the patient's transition time score is greater than a transition time threshold value, the method includes the step of providing 2104 transition time coaching. If the patient's worry time score is greater than a worry time threshold value, the method includes the step of providing 2106 worry time coaching. If the patient's behavioral score is greater than a behavioral threshold value, the method includes the step of providing 2108 behavioral coaching. The relaxation assessment may include such questions/statements as:
Ql : What do you usually do before going to bed? Watching TV, reading, working, using the PC, doing housework, other (checkboxes);
Q2: Would you consider your pre-bed activities as a routine? Yes/no;
Q3: How often do you experience one of the following problems while trying to fall asleep:
My mind keeps turning things over;
My thinking takes a long time to unwind; and
I am unable to empty my mind
(Never, seldom, sometimes, often, very often);
Q4: How often do you find it hard to physically "let go" and relax your body? Never, seldom, sometimes, often, very often;
Q5: How relaxed are you before going to bed? and
Q6: Do you think that stress / high workload makes your sleep poorer? which are converted into the patient's relaxation score. If the lifestyle module is recommended to the patient, the method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing 2110 a lifestyle assessment structured to determine a physical activity score, an alcohol score, a caffeine score, a napping score, a nicotine score, an intake score (i.e. food and/or calorie intake score), and an environment score and determining 2111 a physical activity score, an alcohol score, a caffeine score, a napping score, a nicotine score, an intake score, and an environment score. If the patient's physical activity score is greater than a physical activity threshold value, the method includes the step of providing 2112 physical activity coaching. If the patient's alcohol score is greater than an alcohol threshold value, the method includes the step of providing 2114 alcohol coaching. If the patient's caffeine score is greater than a caffeine threshold value, the method includes the step of providing 2116 caffeine coaching. If the patient's napping score is greater than a napping threshold value, the method includes the step of providing 2118 napping coaching. If the patient's nicotine score is greater than a nicotine threshold value, the method includes the step of providing 2120 nicotine coaching. If the patient's intake score is greater than or less than the intake threshold value (or range), the method includes the step of providing 2122 intake coaching. That is, if the patient is eating too much or too little, the patient will be beyond the intake threshold range. If the patient's environment score is greater than an environment threshold value, the method includes the step of providing 2124 environment coaching. The lifestyle assessment may include, but is not limited to, such questions/statements as:
Q 1 : How often do you exercise and how long? X times per week, y minutes;
Q2: Do you exercise in the 4 hours preceding your bedtime?;
Q3 : How many glasses of alcohol do you drink in the evening?
X glasses beer - wine - stronger (checkboxes);
Q4: How many cups of caffeinated drinks do you drink per day (coffee, tea, cola)? X cups, y of which in the evening;
Q5: Do you take naps? x times per week, y minutes;
Q6: When do you usually nap? Before/after 4 pm (checkboxes);
Q7: Do you smoke? x cigarettes per day;
Q8: Do you smoke before going to bed? In the middle of the night?
Yes/no;
Q9: When you wake up during the night, you often: Eat something?; Have something to drink?; and Got to the bathroom?
QlO: Do you have regular meal times?; QI l: Do you feel sometimes too hot or too cold in your bed?;
Q 12: Do you like your bedroom?;
Q13: Is your sleep sometimes disturbed y noise?; and
Q 14: Is your sleep sometimes disturbed by light? which are converted into the patient's physical activity score, an alcohol score, a caffeine score, a napping score, a nicotine score, an intake score, and an environment score. [106] As noted above, and as shown in Figure 6, the method is, preferably, an iterative process wherein the patient's sleep profile is updated 2130 so as to reflect the patient's current level of insomnia. While the patient input data and the sleeping activity data may be updated every day, preferably the interactive course of therapy is updated regularly, but less frequently than daily. Preferably, the interactive course of therapy is updated weekly. Once the patient's patient sleep profile has been updated, the step of analyzing 2008 a patient sleep profile to determine a course of therapy is repeated. That is, the following steps, and any sub steps may be repeated: the steps of: analyzing 2040 the patient input data and the sleeping activity data to determine the severity of the patient's insomnia; analyzing 2042 the patient input data to determine the severity of the effect of the patient's insomnia on daytime activities; analyzing 2044 the patient input data to determine the type of insomnia suffered by the patient; and, based on the severity of the patient's insomnia, the severity of the effect of the patient's insomnia on daytime activities, and the type of insomnia suffered by the patient, recommending 2046 to the patient one of the following: referral to a medical professional for treatment; recommending an interactive course of therapy to the patient; and recommending no treatment.
[107] Further, as the third processing unit 1010 is structured to send the sleep pattern data, the patient input data and the patient sleep profile to a medical professional via the electronic communications network 1001, the step of analyzing 2008 a patient sleep profile to determine a course of therapy may also include the steps of: having 2050 a medical professional review the sleep pattern data, the patient input data and the patient sleep profile, and having 2052 the medical professional provide direct feedback to the patient via the electronic communications network 1001. These steps may be repeated after an update of the sleep pattern data, the patient input data and the patient sleep profile.
[108] One of ordinary skill in the art will appreciate many variations and modifications within the scope of this invention. This method and system will be used mainly for preferably insomnia patients at home or for patients at home or in hotels, for mobile patients in the hospital environment, during transport or at home but there are also applications possible for hospitalized patients. Also, devices could make use of this invention that are intended for healthy persons or even animals. Further, while the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description are to be considered illustrative or exemplary and not restrictive. The invention is not limited to the disclosed embodiments.
[109] Other variations to the disclosed embodiments can be understood and effected by those skilled in the art in practicing the claimed invention, from a study of the drawings, the disclosure, and the appended claims. In the claims, the word "comprising" does not exclude other elements or steps, and the indefinite article "a" or "an" does not exclude a plurality. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measured cannot be used to advantage. Any reference signs in the claims should not be construed as limiting the scope.
[110] While specific embodiments of the invention have been described in detail, it will be appreciated by those skilled in the art that various modifications and alternatives to those details could be developed in light of the overall teachings of the disclosure. Accordingly, the particular arrangements disclosed are meant to be illustrative only and not limiting as to the scope of invention which is to be given the full breadth of the claims appended and any and all equivalents thereof.

Claims

CLAIMS:
1. A system ( 1000) structured to facilitate cognitive behavioral therapy for a patient having insomnia, said system comprising: a communication assembly (1002) structured to provide for electronic communication; a sensor system (1004) having at least one sensor (1020), said sensor system (1004) structured to detect sleeping activity data and to provide a sensor system signal incorporating said sleeping activity data, said sensor system (1004) coupled to, and in electronic communication with, said communication assembly (1002); a first processing unit (1006) coupled to, and in electronic communication with, said communication assembly (1002), said first processing unit (1006) structured to receive said sensor system signal and to convert said sleeping activity data into sleep pattern data; a second processing unit (1008) having an input assembly (1034) and structured to gather patient input data, said second processing unit (1008) coupled to, and in electronic communication with, said communication assembly (1002); a third processing unit (1010) coupled to, and in electronic communication with, said communication assembly (1002), said third processing unit (1010) structured to receive said sleep pattern data and said patient input data, perform an analysis thereon thereby creating a patient sleep profile; a fourth processing unit (1012) coupled to, and in electronic communication with, said communication assembly (1002), said fourth processing unit (1012) structured to analyze said patient sleep profile and to provide a course of therapy related to said patient sleep profile; and a display (1014) coupled to, and in electronic communication with, said communication assembly (1002), said display (1014) structured to present a user interface (107).
2. The system of Claim 1 wherein said sensor system (1004) includes at least one sensor (1020), each said at least one sensor (1020) being an unobtrusive sensor structured to produce a sensor signal having at least one feature.
3. The system (1000) of Claim 2 wherein: said at least one sensor (1020) includes an ECG sensor (1022) and an acti graph sensor (1024); said ECG sensor (1022) structured to detect heart rate data and respiratory rate data, said heart rate data and respiratory rate data being a feature incorporated into an ECG sensor signal; said actigraph sensor (1024) structured to detect patient body movement data, said patient body movement data being a feature incorporated into an actigraph sensor signal; said first processing unit (1006) structured to extract said heart rate data and respiratory rate data from said ECG sensor signal; said first processing unit (1006) structured to extract said patient body movement data from said actigraph sensor signal; and said first processing unit (1006) structured to process said heart rate data, respiratory rate data, and patient body movement data to determine at least one of said patient's time in bed, said patient's total sleep time, said patient's total wake time, said patient's sleep efficiency, said patient's sleep onset latency, said patient's awakenings after sleep onset and said patient's snooze time.
4. The system (1000) of Claim 1 wherein said third processing unit (1010) is coupled to, and in electronic communication with, an electronic communications network (1001); and said third processing unit (1010) is structured to send said sleep pattern data, said patient input data and said patient sleep profile to a medical professional via said electronic communications network (1001).
5. The system (1000) of Claim 1 wherein: said fourth processing unit (1012) includes a memory device (1050) having stored thereon a plurality of therapeutic instruction modules, said therapeutic instruction modules (1060, 1062, 1064, 1066) structured to be presented on said display (1014); said fourth processing unit (1012) further structured to organize said therapeutic instruction modules (1060, 1062, 1064, 1066) based upon said patient sleep profile; and said fourth processing unit (1012) further structured to present said organized therapeutic instruction modules on said display (1014).
6. A method of providing cognitive behavioral therapy for insomnia, said method comprising the steps: monitoring (2000) a patient's sleep utilizing a sensor system (1000) having at least one unobtrusive sensor, said sensor system (1000) structured to detect sleeping activity data; gathering (2002) patient input data; combining (2006) said patient input data and said sleeping activity data to create a patient sleep profile; analyzing (2008) said patient sleep profile to determine a course of therapy; and presenting (2010) said course of therapy to said patient on a display (1014).
7. The method of Claim 6 wherein said step of monitoring (2000) a patient's sleep utilizing a sensor system (1000) having at least one unobtrusive sensor includes the steps of: utilizing (2020) an ECG sensor (1022) and an actigraph sensor (1024), said ECG sensor (1022) structured to detect heart rate data and respiratory rate data, said actigraph sensor (1024) structured to detect patient body movement data; and processing (2022) said heart rate data, respiratory rate data, and patient body movement data to determine at least one of said patient's time in bed, said patient's total sleep time, said patient's total wake time, said patient's sleep efficiency, said patient's sleep onset latency, said patient's awakenings after sleep onset and said patient's snooze time.
8. The method of Claim 7 wherein said step of gathering (2002) patient input data includes the steps of: gathering (2030) data on said patient's sleep history; gathering (2032) data on said patient's medical history; having (2034) said patient complete an insomnia severity index; and having (2036) said patient maintain a sleep log.
9. The method of Claim 8 wherein said step of analyzing (2008) said a patient sleep profile to determine a course of therapy includes the steps of: analyzing (2038) said patient input data and said sleeping activity data to identify the factors contributing to the patients insomnia; and identifying (2039) the type of insomnia associated with the patient.
10. The method of Claim 8 wherein said step of analyzing (2008) said a patient sleep profile to determine a course of therapy includes the steps of: analyzing (2040) said patient input data and said sleeping activity data to determine the severity of the patient's insomnia; analyzing (2042) said patient input data to determine the severity of the effect of the patient's insomnia on daytime activities; analyzing (2044) said patient input data to determine the type of insomnia suffered by the patient; and based on the severity of the patient's insomnia, the severity of the effect of the patient's insomnia on daytime activities, and the type of insomnia suffered by the patient, recommending (2046) to the patient one of the following: referral to a medical professional for treatment, recommending an interactive course of therapy to said patient, and recommending no treatment.
11. The method of Claim 10 wherein, if an interactive course of therapy is recommended, said steps of analyzing (2008) said patient sleep profile to determine a course of therapy and presenting (2010) said course of therapy to said patient on a display (1014) include the steps of: providing (2050) a plurality of interactive therapeutic instruction modules (1060, 1062, 1064, 1066), each said module related to an aspect of insomnia; based on said patient sleep profile, determining (2052) which of said interactive therapeutic instruction modules (1060, 1062, 1064, 1066) are relevant to the patient's insomnia; determining (2054) the sequence of said interactive therapeutic instruction modules (1060, 1062, 1064, 1066) to be presented to said patient; and presenting (2056), in said predetermined sequence, said interactive therapeutic instruction modules (1060, 1062, 1064, 1066) to said patient on a display (1014).
12. The method of Claim 11 wherein said plurality of interactive therapeutic instruction modules (1060, 1062, 1064, 1066) include a sleep scheduling module (1060), an association bed-sleep module (1062), a cognitive restructuring module (1064), a coping strategy module (1066), a relaxation module (1068), and a lifestyle module (1070).
13. The method of Claim 11 wherein, if said sleep scheduling module (1060) is recommended to the patient, said method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing (2060) a sleep scheduling assessment structured to determine a first and a second sleep scheduling score; determining (2062) the patient's first and second sleep scheduling scores; determining (2064) whether patient has an irregular sleep schedule; if patient's first sleep scheduling score is greater than a first sleep scheduling threshold value, providing (2066) sleep schedule coaching; and if patient has an irregular sleep schedule and if patient's second sleep scheduling score is greater than a second sleep scheduling threshold value, providing (2068) sleep schedule coaching.
14. The method of Claim 11 wherein, if said association bed-sleep module (1062) is recommended to the patient, said method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing (2072) an association bed-sleep assessment structured to determine an association bed-sleep score; and if patient's association bed-sleep score is greater than an association bed-sleep threshold value, providing (2074) association bed-sleep coaching.
15. The method of Claim 11 wherein, if said cognitive restructuring module (1064) is recommended to the patient, said method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing (2080) a first sleep concept assessment structured to determine a first sleep concept score; if patient's a first sleep concept score is greater than a first sleep concept threshold value, performing (2084) a second sleep concept assessment to determine an amplification score, a perceived control score, and an unrealistic expectation score; if patient's amplification score is greater than an amplification threshold value, providing (2086) amplification coaching; if patient's perceived control score is greater than a perceived control threshold value, providing (2088) perceived control coaching; and if patient's unrealistic expectation score is greater than an unrealistic expectation threshold value, providing (2089) unrealistic expectation coaching.
16. The method of Claim 11 wherein, if said coping strategy module (1066) is recommended to the patient, said method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing (2090) a first coping strategy assessment structured to determine a coping strategy score; and if patient's coping strategy score is greater than a coping strategy threshold value, providing (2094) coping strategy coaching.
17. The method of Claim 11 wherein, if said relaxation module (1068) is recommended to the patient, said method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing (2100) a relaxation assessment structured to determine a transition time score, a worry time score, and a behavioral score; if patient's transition time score is greater than a transition time threshold value, providing (2104) transition time coaching; if patient's worry time score is greater than a worry time threshold value, providing (2106) worry time coaching; and if patient's behavioral score is greater than a behavioral threshold value, providing (2108) behavioral coaching.
18. The method of Claim 11 wherein, if said lifestyle module (1070) is recommended to the patient, said method of providing cognitive behavioral therapy for insomnia includes the further steps of: providing (2110) a lifestyle assessment structured to determine a physical activity score, an alcohol score, a caffeine score, a napping score, a nicotine score, an intake score, and an environment score; if patient's physical activity score is greater than a physical activity threshold value, providing (2112) physical activity coaching; if patient's alcohol score is greater than an alcohol threshold value, providing (2114) alcohol coaching; if patient's caffeine score is greater than a caffeine threshold value, providing (2116) caffeine coaching; if patient's napping score is greater than a napping threshold value, providing (2118) napping coaching; if patient's nicotine score is greater than a nicotine threshold value, providing (2120) nicotine coaching; if patient's intake score is greater than an intake threshold value, providing (2122) intake coaching; and if patient's environment score is greater than an environment threshold value, providing (2124) environment coaching.
19. The method of Claim 11 wherein said step of analyzing (2008) said a patient sleep profile to determine a course of therapy includes the steps of: updating (2130) the patient's patient sleep profile with data from said patient input data and said sleeping activity data; and repeating the steps of : analyzing (2040) said patient input data and said sleeping activity data to determine the severity of the patient's insomnia; analyzing (2042) said patient input data to determine the severity of the effect of the patient's insomnia on daytime activities; analyzing (2044) said patient input data to determine the type of insomnia suffered by the patient; and based on the severity of the patient's insomnia, the severity of the effect of the patient's insomnia on daytime activities, and the type of insomnia suffered by the patient, recommending (2046) to the patient one of the following: referral to a medical professional for treatment, recommending an interactive course of therapy to said patient, and recommending no treatment.
20. The method of Claim 11 wherein said step of analyzing (2008) a patient sleep profile to determine a course of therapy may also include the steps of: having (2050) a medical professional review the sleep pattern data, the patient input data and the a patient sleep profile; and having (2052) said medical professional provide direct feedback to the patient via the electronic communications network.
PCT/IB2010/052440 2009-06-04 2010-06-01 Method and system for providing behavioural therapy for insomnia WO2010140117A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2012513716A JP5775868B2 (en) 2009-06-04 2010-06-01 System for providing behavioral therapy for insomnia and control method thereof
RU2011154352/14A RU2568354C2 (en) 2009-06-04 2010-06-01 Behaviour therapy method and system applicable for insomnia management
AU2010255354A AU2010255354A1 (en) 2009-06-04 2010-06-01 Method and system for providing behavioural therapy for insomnia
US13/375,325 US8979730B2 (en) 2009-06-04 2010-06-01 Method and system for providing behavioural therapy for insomnia
CN201080024189.8A CN102448368B (en) 2009-06-04 2010-06-01 Method and system for providing behavioural therapy for insomnia
EP10727937A EP2437652A1 (en) 2009-06-04 2010-06-01 Method and system for providing behavioural therapy for insomnia
BRPI1009049A BRPI1009049A2 (en) 2009-06-04 2010-06-01 "system designed to facilitate cognitive behavioral therapy for a patient with insomnia"

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18416509P 2009-06-04 2009-06-04
US61/184,165 2009-06-04

Publications (1)

Publication Number Publication Date
WO2010140117A1 true WO2010140117A1 (en) 2010-12-09

Family

ID=42617401

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2010/052440 WO2010140117A1 (en) 2009-06-04 2010-06-01 Method and system for providing behavioural therapy for insomnia

Country Status (8)

Country Link
US (1) US8979730B2 (en)
EP (1) EP2437652A1 (en)
JP (1) JP5775868B2 (en)
CN (1) CN102448368B (en)
AU (1) AU2010255354A1 (en)
BR (1) BRPI1009049A2 (en)
RU (1) RU2568354C2 (en)
WO (1) WO2010140117A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102488495A (en) * 2011-12-19 2012-06-13 陈心广 Digitalized intelligent evaluation method for nicotine dependence
CN102551664A (en) * 2010-12-17 2012-07-11 成功大学 Sleep analysis method, sleep analysis table and sleep analysis system
GB2488521A (en) * 2011-02-16 2012-09-05 Cascom Ltd Activity recognition in living species using tri-axial acceleration data
CN102908711A (en) * 2011-08-02 2013-02-06 索尼公司 Sleep aid device and method, program and recording medium
CN103892797A (en) * 2012-12-31 2014-07-02 中国移动通信集团公司 Signal processing method and device for sleep structure analysis
FR3008300A1 (en) * 2013-07-12 2015-01-16 Ile Marc Frouin Soc Civ DEVICE FOR MONITORING A PHYSIOLOGICAL CONDITION AND ALERT THROUGH AN INTELLIGENT CLOTHING WITH INTEGRATED BIOMETRIC SENSORS, AN APPLICATION AND A CLOUD SYSTEM
US20150080756A1 (en) * 2012-01-27 2015-03-19 The University Of Sydney Estimating arousal states
TWI553584B (en) * 2014-10-24 2016-10-11 國立清華大學 Evaluation system, method and computer program product of relaxation state
US9633175B2 (en) 2013-02-05 2017-04-25 Big Health Ltd Interactive system for sleep improvement
WO2018001758A1 (en) 2016-06-27 2018-01-04 Koninklijke Philips N.V. Determination system and method for determining a sleep stage of a subject
JP2018519967A (en) * 2015-07-21 2018-07-26 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Method and system for automatic labeling of activities in ECG data
KR20190092765A (en) 2018-01-31 2019-08-08 박성규 Method for providing insomnia mediation service and apparatus therefor
CN114191684A (en) * 2022-02-16 2022-03-18 浙江强脑科技有限公司 Sleep control method and device based on electroencephalogram, intelligent terminal and storage medium

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5803169B2 (en) * 2011-03-14 2015-11-04 オムロンヘルスケア株式会社 Sleep evaluation apparatus and sleep evaluation method
US9152768B2 (en) * 2011-09-26 2015-10-06 Hill-Rom Services, Inc. Method and system for patient care management
JP5788293B2 (en) * 2011-10-31 2015-09-30 オムロンヘルスケア株式会社 Sleep evaluation apparatus and sleep evaluation program
US9339691B2 (en) 2012-01-05 2016-05-17 Icon Health & Fitness, Inc. System and method for controlling an exercise device
JP6522342B2 (en) * 2012-01-06 2019-05-29 シグニファイ ホールディング ビー ヴィ Emergency response and tracking using lighting networks
US10856800B2 (en) * 2012-06-08 2020-12-08 United States Government As Represented By The Department Of Veterans Affairs Portable polysomnography apparatus and system
CA2925804A1 (en) * 2012-09-26 2014-04-03 Seth D. Feuerstein Combination methods and compositions including sleep therapeutics for treating mood
EP2969058B1 (en) 2013-03-14 2020-05-13 Icon Health & Fitness, Inc. Strength training apparatus with flywheel and related methods
US11813076B2 (en) 2013-03-15 2023-11-14 Sleepme Inc. Stress reduction and sleep promotion system
US11883606B2 (en) 2013-03-15 2024-01-30 Sleep Solutions Inc. Stress reduction and sleep promotion system
US11602611B2 (en) 2013-03-15 2023-03-14 Sleepme Inc. System for enhancing sleep recovery and promoting weight loss
US11896774B2 (en) 2013-03-15 2024-02-13 Sleep Solutions Inc. System for enhancing sleep recovery and promoting weight loss
EP3937107A1 (en) 2013-05-21 2022-01-12 Tomer Ben-Kiki Systems and methods for providing on-line services
US10813584B2 (en) 2013-05-21 2020-10-27 Happify, Inc. Assessing adherence fidelity to behavioral interventions using interactivity and natural language processing
US20190129941A2 (en) 2013-05-21 2019-05-02 Happify, Inc. Systems and methods for dynamic user interaction for improving happiness
CN104720746B (en) * 2013-12-20 2017-06-20 中国移动通信集团公司 A kind of sleep stage determines method and system
WO2015100429A1 (en) 2013-12-26 2015-07-02 Icon Health & Fitness, Inc. Magnetic resistance mechanism in a cable machine
US9655559B2 (en) * 2014-01-03 2017-05-23 Vital Connect, Inc. Automated sleep staging using wearable sensors
US9579060B1 (en) 2014-02-18 2017-02-28 Orbitol Research Inc. Head-mounted physiological signal monitoring system, devices and methods
US10433612B2 (en) 2014-03-10 2019-10-08 Icon Health & Fitness, Inc. Pressure sensor to quantify work
US9694156B2 (en) 2014-06-05 2017-07-04 Eight Sleep Inc. Bed device system and methods
US9186479B1 (en) 2014-06-05 2015-11-17 Morphy Inc. Methods and systems for gathering human biological signals and controlling a bed device
US10426989B2 (en) 2014-06-09 2019-10-01 Icon Health & Fitness, Inc. Cable system incorporated into a treadmill
WO2015195965A1 (en) 2014-06-20 2015-12-23 Icon Health & Fitness, Inc. Post workout massage device
JP6385470B2 (en) * 2014-06-30 2018-09-05 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Device, system and computer program for detecting the health condition of a subject
US20160192218A1 (en) * 2014-07-14 2016-06-30 Under Armour, Inc. Techniques for classifying sleep sessions
US20160034671A1 (en) * 2014-07-29 2016-02-04 Elwha Llc Method and Apparatus for Designating Patients According to Sleep Patterns
US20160035056A1 (en) * 2014-07-29 2016-02-04 Elwha Llc Method and Apparatus for Designating Patients According to Sleep Patterns
EP3195243A4 (en) * 2014-07-29 2018-04-04 Elwha LLC Method and apparatus for designating patients according to sleep patterns
US20160035057A1 (en) * 2014-07-29 2016-02-04 Elwha Llc Method and Apparatus for Designating Patients According to Sleep Patterns
WO2016083294A1 (en) * 2014-11-24 2016-06-02 Tarkett Gdl Monitoring system with pressure sensor in floor covering
WO2016087983A1 (en) * 2014-12-03 2016-06-09 Koninklijke Philips N.V. System and method for increasing the restorative value of a nap
JP6761417B2 (en) * 2014-12-19 2020-09-23 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Dynamic wearable device behavior based on schedule detection
JP2016122348A (en) * 2014-12-25 2016-07-07 オムロン株式会社 Life style improvement apparatus, life style improvement method and life style improvement system
JP6485037B2 (en) * 2014-12-25 2019-03-20 オムロン株式会社 Sleep improvement system and sleep improvement method using the system
US10391361B2 (en) 2015-02-27 2019-08-27 Icon Health & Fitness, Inc. Simulating real-world terrain on an exercise device
US10542961B2 (en) 2015-06-15 2020-01-28 The Research Foundation For The State University Of New York System and method for infrasonic cardiac monitoring
WO2017053728A1 (en) * 2015-09-23 2017-03-30 Emfit, Corp. Heart rate monitoring device, system, and method for increasing performance improvement efficiency
US10213145B1 (en) * 2015-10-01 2019-02-26 Cerner Innovation, Inc. Context-aware post traumatic stress disorder monitoring and intervention
CN113499062A (en) * 2015-10-07 2021-10-15 普莱柯迪尔公司 Method and apparatus for generating information indicative of a cardiac condition
US10154932B2 (en) 2015-11-16 2018-12-18 Eight Sleep Inc. Adjustable bedframe and operating methods for health monitoring
US10105092B2 (en) 2015-11-16 2018-10-23 Eight Sleep Inc. Detecting sleeping disorders
WO2017136464A1 (en) 2016-02-01 2017-08-10 Prevencio, Inc. Diagnostic and prognostic methods for cardiovascular diseases and events
US10272317B2 (en) 2016-03-18 2019-04-30 Icon Health & Fitness, Inc. Lighted pace feature in a treadmill
US10625137B2 (en) 2016-03-18 2020-04-21 Icon Health & Fitness, Inc. Coordinated displays in an exercise device
US10493349B2 (en) 2016-03-18 2019-12-03 Icon Health & Fitness, Inc. Display on exercise device
CN107920753B (en) * 2016-05-09 2021-08-27 皇家飞利浦有限公司 Sleep monitoring
US10325514B2 (en) * 2016-06-02 2019-06-18 Fitbit, Inc. Systems and techniques for tracking sleep consistency and sleep goals
US20180085050A1 (en) * 2016-09-28 2018-03-29 Arizona Board Of Regents On Behalf Of The University Of Arizona Systems and methods for individualized sleep optimization
US10671705B2 (en) 2016-09-28 2020-06-02 Icon Health & Fitness, Inc. Customizing recipe recommendations
MX2019004220A (en) * 2016-10-11 2019-08-26 Sustainable Medicine Inc Insomnia treatment assistance device and insomnia treatment assistance program.
US20180113991A1 (en) * 2016-10-26 2018-04-26 Sarah Davidson Interactive Apparatus and Devices for Personal Symptom Management and Therapeutic Treatment Systems
WO2018077844A1 (en) 2016-10-28 2018-05-03 Telefonica Innovacion Alpha S.L. System and a method for enabling responsive cognitive behavioral therapy
EP3609390A4 (en) * 2017-04-14 2020-09-16 Emfit Ltd. Wearable sensor and system thereof
CN107169272B (en) * 2017-05-04 2020-03-27 北京心海导航教育科技股份有限公司 Cognitive behavior training method and system
CN107657748A (en) * 2017-10-20 2018-02-02 深圳市华达康科技有限公司 A kind of Internet of Things intelligent sharing mattress adds hotel's ecological chain operation system and method
TWI698223B (en) * 2017-11-20 2020-07-11 金寶電子工業股份有限公司 Wearable device capable of recognizing doze-off stage and recognition method thereof
CN108010569A (en) * 2017-12-28 2018-05-08 曹亮明 A kind of assistant interventional psychosomatic disease and the intelligent physical therapeutic system of insomnia
GB2584242B (en) 2018-01-09 2022-09-14 Eight Sleep Inc Systems and methods for detecting a biological signal of a user of an article of furniture
GB2584241B (en) 2018-01-19 2023-03-08 Eight Sleep Inc Sleep pod
SE1850792A1 (en) * 2018-06-26 2020-01-28
WO2020082115A1 (en) * 2018-10-22 2020-04-30 Alertness CRC Ltd Decision support software system for sleep disorder identification
WO2020087114A1 (en) * 2018-10-29 2020-05-07 Alertness CRC Ltd Personalised sleep scheduler
US11382560B2 (en) * 2019-03-28 2022-07-12 The Trustees Of The University Of Pennsylvania Systems and methods for sleep optimization
JP2022551816A (en) * 2019-09-21 2022-12-14 マイカーディオ エルエルシー Systems and methods for specifying REM and wakefulness states
EP4051091B1 (en) 2019-10-31 2023-08-02 ResMed Sensor Technologies Limited Systems for insomnia screening and management
US20210282706A1 (en) * 2020-03-16 2021-09-16 Koninklijke Philips N.V. Characterizing stimuli response to detect sleep disorders
US11837106B2 (en) * 2020-07-20 2023-12-05 Koninklijke Philips N.V. System and method to monitor and titrate treatment for high altitude-induced central sleep apnea (CSA)
CN112717254B (en) * 2020-12-24 2022-10-04 重庆适领科技有限公司 Control method of intelligent aromatherapy fragrance expander system
JP6928413B1 (en) * 2021-03-09 2021-09-01 サスメド株式会社 Insomnia treatment support device, insomnia treatment support system and insomnia treatment support program
US20220344057A1 (en) * 2021-04-27 2022-10-27 Oura Health Oy Method and system for supplemental sleep detection
KR20220156466A (en) * 2021-05-18 2022-11-25 연세대학교 원주산학협력단 System for improving sleep quality and method using the same
CN113288095B (en) * 2021-05-24 2022-07-08 南京优博一创智能科技有限公司 Sleep health management method and system for calculating sleep cycle based on physical activity and heart rate information
CN113398424A (en) * 2021-07-13 2021-09-17 正岸(北京)科技有限公司 Insomnia treatment system and working method thereof
US20240082532A1 (en) * 2022-09-08 2024-03-14 Sleep Number Corporation Bed with features for determination of insomnia risk
CN117224098B (en) * 2023-09-15 2024-02-20 广州麦笛亚医疗器械有限公司 Evaluation method, system, equipment and storage medium for heart rate variability

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0773504A1 (en) 1995-11-08 1997-05-14 Oxford Medical Limited Improvements relating to physiological monitoring
WO2004078132A2 (en) 2003-02-28 2004-09-16 Consolidated Research Of Richmond, Inc. Automated insomnia treatment system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000000214A (en) * 1998-06-15 2000-01-07 Arata Nemoto Sleeping monitor device
ES2515092T3 (en) * 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator and methods of improving sleep quality and treating depression
US7524279B2 (en) * 2003-12-31 2009-04-28 Raphael Auphan Sleep and environment control method and system
US8403865B2 (en) * 2004-02-05 2013-03-26 Earlysense Ltd. Prediction and monitoring of clinical episodes
US20070118054A1 (en) 2005-11-01 2007-05-24 Earlysense Ltd. Methods and systems for monitoring patients for clinical episodes
JP2006006355A (en) * 2004-06-22 2006-01-12 Sony Corp Processor for biological information and video and sound reproducing device
CN101032402A (en) * 2006-03-10 2007-09-12 通用电气公司 Device, system and method for detecting human's movement
US20080275349A1 (en) * 2007-05-02 2008-11-06 Earlysense Ltd. Monitoring, predicting and treating clinical episodes
US7637859B2 (en) * 2007-06-08 2009-12-29 Sony Ericsson Mobile Communications Ab Sleeping mode accessory
WO2009061455A1 (en) * 2007-11-07 2009-05-14 Somerset Medical Center A method and system for identification and management of patients for sleep disorders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0773504A1 (en) 1995-11-08 1997-05-14 Oxford Medical Limited Improvements relating to physiological monitoring
WO2004078132A2 (en) 2003-02-28 2004-09-16 Consolidated Research Of Richmond, Inc. Automated insomnia treatment system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2437652A1

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102551664A (en) * 2010-12-17 2012-07-11 成功大学 Sleep analysis method, sleep analysis table and sleep analysis system
GB2488521A (en) * 2011-02-16 2012-09-05 Cascom Ltd Activity recognition in living species using tri-axial acceleration data
CN102908711A (en) * 2011-08-02 2013-02-06 索尼公司 Sleep aid device and method, program and recording medium
CN102488495A (en) * 2011-12-19 2012-06-13 陈心广 Digitalized intelligent evaluation method for nicotine dependence
US20150080756A1 (en) * 2012-01-27 2015-03-19 The University Of Sydney Estimating arousal states
CN103892797A (en) * 2012-12-31 2014-07-02 中国移动通信集团公司 Signal processing method and device for sleep structure analysis
US9633175B2 (en) 2013-02-05 2017-04-25 Big Health Ltd Interactive system for sleep improvement
FR3008300A1 (en) * 2013-07-12 2015-01-16 Ile Marc Frouin Soc Civ DEVICE FOR MONITORING A PHYSIOLOGICAL CONDITION AND ALERT THROUGH AN INTELLIGENT CLOTHING WITH INTEGRATED BIOMETRIC SENSORS, AN APPLICATION AND A CLOUD SYSTEM
TWI553584B (en) * 2014-10-24 2016-10-11 國立清華大學 Evaluation system, method and computer program product of relaxation state
JP2018519967A (en) * 2015-07-21 2018-07-26 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Method and system for automatic labeling of activities in ECG data
WO2018001758A1 (en) 2016-06-27 2018-01-04 Koninklijke Philips N.V. Determination system and method for determining a sleep stage of a subject
CN109328034A (en) * 2016-06-27 2019-02-12 皇家飞利浦有限公司 For determining the determination system and method for the sleep stage of object
RU2704787C1 (en) * 2016-06-27 2019-10-30 Конинклейке Филипс Н.В. System and method of determining for determining a stage of sleep of a subject
US10624574B2 (en) 2016-06-27 2020-04-21 Koninklijke Philips N.V. Determination system and method for determining a sleep stage of a subject
KR20190092765A (en) 2018-01-31 2019-08-08 박성규 Method for providing insomnia mediation service and apparatus therefor
KR102141804B1 (en) * 2018-01-31 2020-08-06 박성규 Method for providing insomnia mediation service and apparatus therefor
CN114191684A (en) * 2022-02-16 2022-03-18 浙江强脑科技有限公司 Sleep control method and device based on electroencephalogram, intelligent terminal and storage medium
CN114191684B (en) * 2022-02-16 2022-05-17 浙江强脑科技有限公司 Sleep control method and device based on electroencephalogram, intelligent terminal and storage medium

Also Published As

Publication number Publication date
BRPI1009049A2 (en) 2016-03-08
RU2011154352A (en) 2013-07-20
US20120238800A1 (en) 2012-09-20
JP2012528655A (en) 2012-11-15
CN102448368A (en) 2012-05-09
EP2437652A1 (en) 2012-04-11
JP5775868B2 (en) 2015-09-09
CN102448368B (en) 2015-05-27
RU2568354C2 (en) 2015-11-20
AU2010255354A1 (en) 2012-02-02
US8979730B2 (en) 2015-03-17

Similar Documents

Publication Publication Date Title
US8979730B2 (en) Method and system for providing behavioural therapy for insomnia
EP2265173B1 (en) Method and system for sleep/wake condition estimation
Paalasmaa et al. Unobtrusive online monitoring of sleep at home
RU2634624C2 (en) System and method for determination of human sleep and sleep stages
US9519755B2 (en) Method and system for evaluating a physiological state depicting a person's resources
US8666482B2 (en) Method, system and software product for the measurement of heart rate variability
RU2704787C1 (en) System and method of determining for determining a stage of sleep of a subject
WO2008096307A1 (en) Sleep management
KR101383199B1 (en) Well-being pillow system
CN111820879A (en) Health evaluation management method suitable for chronic disease patients
JP2014039586A (en) Sleep improvement support device
Paalasmaa Monitoring sleep with force sensor measurement
GB2469547A (en) Measurement of heart rate variability
Alharbi Non-invasive Wearable Solutions to Identify Individuals with Mild Cognitive Impairments from Healthy Controls
Ryser Movement-based sleep detection–a wearable sensor system to assess quantity and quality of sleep
TW202403777A (en) Health state determination method and health state determination system
Williams Investigating the Relationship between Sleep and Wake Behavior Using Machine Learning and Smart Home Sensors
Wongdhamma Statistical models for detecting existence of obstructive sleep apnea, predicting its severity, and forecasting future episodes

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080024189.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10727937

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2010727937

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012513716

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 9707/CHENP/2011

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2010255354

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2011154352

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2010255354

Country of ref document: AU

Date of ref document: 20100601

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13375325

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: PI1009049

Country of ref document: BR

ENP Entry into the national phase

Ref document number: PI1009049

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20111130